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ABSTRACT OF DISSERTATION

Genetic Association Testing of Copy Number Variation
Copy-number variation (CNV) has been implicated in many complex diseases. It is of
great interest to detect and locate such regions through genetic association testings.
However, the association testings are complicated by the fact that CNVs usually span
multiple markers and thus such markers are correlated to each other. To overcome
the diculty, it is desirable to pool information across the markers. In this thesis, we
propose a kernel-based method for aggregation of marker-level tests, in which rst we
obtain a bunch of

p-values

through association tests for every marker and then the

association test involving CNV is based on the statistic of

p-values

combinations. In

addition, we explore several aspects of its implementation.
Since

p-values

among markers are correlated, it is complicated to obtain the null dis-

tribution of test statistics for kernel-base aggregation of marker-level tests. To solve
the problem, we develop two proper methods that are both demonstrated to preserve
the family-wise error rate of the test procedure -a permutation-based approach and
a correlation-base approach. Many implementation aspects of kernel-based method
are compared through the empirical power studies in a number of simulations constructed from real data involving a pharmacogenomic study of gemcitabine. In addition, more performance comparisons are shown between permutation-based and
correlation-based approach. We also apply those two approaches to the real data.
The main contribution of the dissertation is the development of marker-level association testing, a comparable and powerful approach to detect phenotype-associated
CNVs. Furthermore, the approach is extended to high dimension setting with high
eciency.
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Chapter 1 Introduction

1.1

Genetic background of Copy number variation

An allele is one of a number of alternative forms of the same gene or same genetic locus that is located at a specic position on a specic chromosome. Genetic variation
is the variation in alleles of genes and it occurs both within and among populations. It is brought about by mutation, a change in the chemical structure of a gene.
Due to the improved understanding of variation in human DNA and development of
high-resolution assays that capable of detecting small segmental genetic alteration,
dierent kinds of genetic variation have been detected.

These variations present

in an unexpected amount of forms, including single-nucleotide polymorphism, small
insertion-deletion polymorphisms, variable numbers of repetitive sequences, and genomic structural variation. Initial genetic variation studies mostly concentrated on
single-nucleotide polymorphisms (SNP). A SNP is a DNA sequence variation that
occurs when a single nucleotide (A,T,C or G) in a DNA sequence diers between
individuals. It is a single base change in the DNA. SNPs are thought to be the most
common form of genetic variation. In 2001 it was discovered that there are at least estimated 10 million SNPs commonly occurring within the human population [1]. The
international HapMap Project has identied over 3.1 million SNPs across the human
genome that commonly exist in the individuals of African, Asian and European ancestry. SNPs have been considered to be the main source of normal phenotypic variation
for decades. However, a study by Maher [2] demonstrates that most common single
nucleotide polymorphisms associated with complex diseases have small eect size and
explained only

2−15% of heritable variation.

Increasingly researchers have attempted

to discover other type of variation that might account for the remaining fraction of
the heritable variation.

1

Prior to the day of DNA sequencing, very few gene number changes could be
detected by a microscope.

During the past several years, hundreds of new forms

of variation in repetitive regions of DNA have been identied.

Two groups of re-

searchers published landmark ndings of detection of copy number variation among
the genomes of healthy individuals [3, 4]. Subsequent studies using more developed
methods expanded the results and provided more evidence for the existence of such
variation over large portions of the human genome. The number of copies of a segment of DNA in the genome is referred to as the DNA copy number for that segment.
Normally, most individuals have two copies of a given genomic segment of DNA.
A dierent number of copies results when an individual goes through one or more
deletions or duplications of a segment.

Therefore, by choosing a genome reference

sequence, which is considered to have a "normal" number of copies, any individuals
with an abnormal number of copies at the same genomic region are dened to possess
a CNV at that region.

Copy number variants are now known to be a prevalent form of genetic variation
and account for a substantial proportion of genetic variability in human populations.
CNVs are categorized in many ways. Some authors subclassify CNVs in terms of the
size and frequency. Traditionally, CNV is dened as one type of structural variant
in a segment of DNA that is 1 kb or larger [5].

By the improvement of detection

technology, shorter segments are able to be detected and now also considered. Some
publications dened it with minor allele frequency (MAF). In a recent study [6],

> 90%

of CNVs involved copy-number polymorphism that occurs in more than 1%

of the given population and
ing

10%

> 80%

common CNPs with MAF

> 5%.

The remain-

consists of rare CNVs. This indicates that a large portion of copy number

variation come from common polymorphisms. By comparing the human genome ref-

2

erence sequence with another genome sequence using the fosmid paired-end sequence
approach, Tuzun identied 297 sites of potential structure variation between the two
sequences, including 139 insertions, 102 deletion, and 56 inversions. [7]. The number
of identied CNVs is now increasing dramatically as the detection technologies have
improved. To date, approximately 180,000 CNV have been reported in the Database
of Genomic Variants (DGV), which records information about identied copy number
events. We make no distinction in forms of size or frequency in this dissertation and
use the term CNV for all kinds of copy number variation.

More and more studies demonstrate the potentially greater role of CNVs than
single base-pair sequence variation. It was estimated that
be aected by CNV in comparison to
phisms (SNPs) [8].

Ridon et al.

1 − 2%

12%

of the genome could

covered by single nucleotide polymor-

constructed a rst-generation CNV map of the

human genome after studying 270 individuals. They identied a total of 1,447 copy
number variable regions covering

12%

of genome in these population.

Another re-

search team pointed out that there are approximately 12 CNVs per entire genome
on average [3, 4]. But these results were based on the small number of genomes and
limited resolution of previous detection methods. Sharp et al. revealed that

61%

of

the variants identied had not been discovered before [9]. It seems that the number
of CNVs is underestimated. By 2006, it appears that 1237 CNVs covering an estimated 143 Mb genomic sequence had been identied, which is a substantial source of
genomic variation except SNP [10]. Analysis of the complete DNA sequence from a
single individual reported that CNVs account for about
in the individual and

74%

22%

of all genetic variation

of the total DNA sequence variation [11]. It is reasonable

to conclude that CNV accounts for an appreciable amount of phenotypic variation.

3

An increasing number of studies are investigating the impact of copy number variation on various phenotypes. The duplication of the Bar gene in Drosophila was one
of the earliest studies on association of CNV with a phenotype. The variation was
shown to cause the Bar eye phenotype, which will narrow the eye eld of aected
ies [12]. Another popular example is the duplication of part or all of chromosome
21 has been discovered to be linked to Down syndrome. More evidence reveals that
changes in copy number play an important role in evolution. A study by Stefansson et
al. [13] identied a common inversion with frequency of

20%

in Europeans that indi-

cates positive selection. They analyzed tens of thousands of samples and investigated
that the inversion carrier females have more children than noncarriers.

Numerous

examples of relevance between CNVs and complex diseases were observed by Redon
et al. [14]. CNVs are also found to be associated with Prader-Willi and Angelman
syndromes. Sebat et al. discovered association between deletion variation and risk
of autism [15]. Walsh et al. reported the contribution to schizophrenia disease and
Zhang et al. presented the risk to bipolar disorder [16, 17].

Copy number variants do not necessarily have a negative eect on health. A number of studies provided the evidence that some specic large duplication or deletion do
not apparently result in disease [1821]. In 2004, two groups independently detected
the widespread presence of CNVs among the genomes of healthy individuals. [3, 4].
By constructing a targeted bacterial articial chromosome (BAC) microarray, 119
regions of CNVs were identied, with 73 unreported previously, on a panel of 47 normal individuals representing four dierent population. The study also demonstrated
that segmental duplications occur at hotspots of chromosome rearrangement, acting
as causes of normal variants as well as genetic disease [9].

4

1.2

CNV calling

It has became one of the compelling genetics challenges during the last few years
to understand the contribution of copy number variation to the phenotypes such as
disease state. As many CNVs are rare, it is dicult to conduct statistically signicant association between a single rare CNV and the disease status. Instead, several
studies examine the association between phenotype and total CNVs in the whole chromosome. Through case-control testing, these studies identied associations between
copy number changes and various diseases, including autism, schizophrenia and bipolar disorder [1517]. Previous studies of copy-number variation in human populations
have largely been restricted to hundreds of individuals and therefore were unable to
distinguish variants that are truly rare. More and more recent studies have begun to
expand to substantially larger sample size.

Genome-wide association studies (GWAS) in large samples of cases and controls
are commonplace and therefore an ecient approach is to carry out association studies involving CNVs using the same data. GWAS is an examination of genetic variation
across human genome. It tests markers across the complete sets of genomes of many
people to identify genetic association with clinical phenotypes. Researchers use two
groups of participants to conduct the study: people with the disease (case) and similar people without the disease (control). The entire genome, which contains millions
of genetic variants, is investigated through the case-control testing. If a certain variant is found to be signicantly more frequent in people with disease, this type of
variation is said to be "associated" with the disease. The associated variant might
not directly cause the disease and is considered to be "tagging along" with the actual
casual variant. In a typical GWAS, genetic variants are read by SNP arrays, a more
popular and common type of DNA microarray data used to detect polymorphisms
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within a population. Hence, GWAS typically presents the associations between singlenucleotide polymorphisms (SNPs) and the observed traits. GWAS was rst applied in
2005 on patients with age-related macular degeneration(AMD) and two SNPs were
detected to inuence the risk of disease by case-control testing.

Such studies are

substantially useful and have already successfully identied hundreds of genetic variations contributing to common, complex diseases. GWA studies often require a large
number of samples in order to obtain a reliable signal of risk-SNPs. It was reported
by Ehret et al. [22] that the largest sample size was in the range of 200,000 individuals.

There have been several techniques proposed for measuring copy-number variation.

Traditionally, large chromosome rearrangements have been detected with

G-banded karyotypic analyses or uorescence in situ hybridization (FISH) using
uorescent probes that bind to part of the chromosomes.

With the development

of microarray technology, array-based comparative genomic hybridization (aCGH)
was one of the widely used techniques.

This technology was rst introduced as

"matrix-CGH" [23]. This technique involves labeling a reference genome and a testing genome with dierent uorescence markers, hybridizing to the microarray with
genomic clones, and then analyzing the intensity of the hybridization signal for each
clone. Then the array-CGH technique has been through a lot of improvements such as
BAC Array Comparative Genomic Hybridization, Representational Oligonucleotide
Microarray Analysis (ROMA) and Agilent CGH [24] to detect CNVs in human populations.

The CNV studies were restricted to a list of selected candidate genes due to the
cost and complexity of CNV assessment.

High-throughput single nucleotide poly-

morphism (SNP)-array technologies provide possibility to investigate copy number

6

variants (CNVs) in genome-wide scans and specic calling algorithms have been developed to determine CNV location and copy number. High-density single nucleotide
polymorphism (SNP) genotyping arrays have recently become more popular for CNV
detection and analysis, because the arrays are available for both SNP-based and CNVbased association studies. Furthermore, they provide considerably higher precision
and resolution than traditional techniques.

Since vast amounts of these data have

been already generated during the pursuit of conducting genome-wide association
studies (GWAS) among SNPs, it has tremendous advantages and merits in terms of
convenience and low expense for studies. Hence it is expected to continue to be the
main approach for several years to come.

However, there are limitations to using

SNP genotyping arrays for CNV detection. One obvious limitation is that SNPs are
not uniformly distributed across the genome and are sparse in regions with segmental
duplication or deletions [25]. The new-generation SNP arrays, such as the Innium
Illumina Human 1Million probe chip and the Aymetrix 6.0 platform, have now incorporated additional nonpolymorphic (NP) markers to provide more comprehensive
coverage of the human genome and thus overcome this limitation. They are proven
to be a method for detecting CNVs and now are commonly used to obtain the copynumber measurement recently. In my thesis, I focus here on detection of coy-number
variation using raw data from genome-wide single nucleotide polymorphism (SNP)
arrays.

In high-density SNP genotyping platforms, a signal intensity measure is summarized for each allele of any SNP. Thus, each marker from SNP arrays consists
of two intensity measurements, corresponding to the A and B allele [26, 27]. First,
quantile-normalization is required for each probe intensity.

After normalization of

both intensities, a polar coordinate transformation is applied, generating two parameters

R

and

θ. R

refers to the sum of normalized intensities for both alleles and

7

θ

is called as an allelic intensity ratio representing the relative allelic intensity ratio of
two alleles. The observed normalized intensity
the expected value of

R

R

from a subject is then compared to

given neutral copy number, which is computed from linear

interpolation of canonical genotype clusters (AA, AB and BB) obtained from a large
set of reference samples. Such comparison thus generates a
transformation is applied to the

R

R

ratio. Finally, a log

ratios. The result, which is called the log

R

ratio

(LRR), is reported along the whole genome for every single marker on the array.
LRR serves as a continuous measurement of copy number.

A position or a region

with no CNV presenting should have LRR equal to zero. Higher LRR intensities are
signals of copy number gain at those positions in the test samples and similarly lower
LRRs indicate the copy number loss. Analysis of signal intensities across the genome
can then be used to identify regions with CNVs [26]. Because of the LRR noise, the
drop or increase in LRR might not be obvious. Therefore, it is necessary to apply
statistical methods to distinguish the signal from noise.

There are broadly two main estimation goals for CNV detection - inferring the
copy numbers and accurately locating the CNV boundaries. There have been numerous publications proposing methods to segment a genome into various regions of constant copy number, which is called "CNV calling". Some methods involve a penalized
likelihood to estimate the breakpoint(CGHseg), using an expectation-maximizationbased technique (ChARM) and building hierarchical clustering-style trees along each
chromosome (CLAC) [28, 29]. Other papers introduce Bayesian method, the use of a
genetic local search algorithm (GA), a wavelet approach(Wavelet), and an extension
of the SW-ARRAY algorithm to identify potential breakpoints. Additional proposals
include Quantile Smoothing (Quantreg), adaptive weights smoothing (GLAD) and
analysis of copy errors (ACE). Hidden Markov model (HMM), circular binary segmentation (CBS), and fused lasso are the most commonly applied techniques.
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We

present here the description of circular binary segmentation.

First proposed by Olshen et al. [30], circular binary segmentation (CBS) is a
non-parametric modied change-point method. As CNVs often extend over multiple
markers, it is more resonable to focus on a whole chromosome combining information
from neighboring markers than analysis on single one marker at a time.

By con-

necting the two ends of each chromosome, the method oers a nice way to split the
chromosome into contiguous regions of constant copy number and model into discrete
copy number gains and losses at the same time. Bypassing parametric modeling of
the data, it uses a permutation reference distribution to assess the signicance of
the proposed splits. The selection process, which recursively splits each contiguous
segment, is performed until there is no more signicant splits among chromosome.
Lai et al.

reported that CBS performs consistently well compared to other 10 ap-

proaches [29].

The main idea behind circular binary segmentation(CBS) is summarized as follows. It uses log R ratios (LRR) as input data and analyzes on each chromosome of
a single individual,

1. Joining the rst and the last marker of the chromosome, the sequence of LRR
intensities become circular.

2. For every potential way of splitting the circle into complimentary arcs, compute
the two-sample t-statistics to compare the means between two arcs

3. Segment the circle somewhere that the maximum of test statistics exceeds the
critical value
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4. Repeat 2-3 steps recursively for testing the change-points until no additional
signicant segment can be found

The details of the procedure are presented in these two papers [30,31]. The R package
DNAcopy is used to conduct the analysis. It is a package of the Bioconductor project
and is available at http://www.bioconductor.org/packages/release/bioc/html/DNAcopy.html.
It provides the estimates of the mean LRR at every marker among the given genome
for output. Those estimates are constant over each arc and therefore give an estimation of the CNV structure. DNAcopy is considered to be one of the best operational
algorithm in terms of its sensitivity and FDR criterion for breakpoint detection [28].
Unfortunately, DNAcopy is also one of the slowest algorithms [29].

A number of articles [28, 29, 3234] have compared numerous methods or algorithms that are adapted for CNV calling. There are no best or optimal algorithm so
far. Each algorithm uses dierent strategy for CNV calling and thus there are obvious variabilities among calling algorithms. The emerging algorithms have dierent
assumptions for CNV detection. In other word, dierent CNV calling algorithm provides substantially dierent quantity and quality of CNV calls even for identical raw
data. Therefore, the choice of analysis tools is very important for CNV association
studies. Some authors have advised using multiple algorithms on the same data to
minimize the false discoveries and thus merging call sets from those algorithms could
improve sensitivity [33].

Careful normalization of the intensity is required because

hybridization signals are very sensitive to experimental noise that might result in even
opposite inference. Furthermore, the accurate CNV detection depends on the choice
of the array data. Pinto et al. pointed out that some methods are developed specically for a certain array data and thus perform always better than other algorithms
only in such array data [33]. Additionally, many algorithms developed generally per-
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form well for identifying large CNVs. Attempting to localize small CNVs even with
only one single probe, it results in many false positives.

In conclusion, eorts are

ongoing to improve methods for CNV calling at the genome-wide level and test for
association in large samples of cases and controls.

1.3

Marker-level testing

Two general strategies have been proposed for conducting genetic association studies
of copy-number variation. The rst approach, which we refer to as variant-level testing, is to do "CNV calling" at the level of each individual rst and then carry out
association tests of whether individuals with a CNV dier from individuals without
a CNV with respect to some phenotype. It is the more popular strategy for testing
CNV associations. However, the result of this test mainly depends on the detection of
CNV regions in the rst step. Moreover, it is still challenging to separate each genome
into regions of constant copy number as discussed in last section. Furthermore, there
are additional complications for the variant-level approach. One of the big issues is
partially overlapping CNVs. Since CNVs are detected person by person, CNVs do not
necessarily share the same boundaries. When the sample size gets large, the number of overlapping patterns may be considerable. Whether those represent the same
CNV or dierent CNVs can be a complicated decision. Also, because CNVs do not
overlap perfectly among individuals, the association tests are correlated, leading to
problems when doing multiple testing. Moreover, it eects the association test when
using dierent threshold to declare a CNV present. If the threshold is too high, true
CNVs might be undetected; if the threshold is too low, neutral regions would be dened as CNVs and thus create misclassication and lower power of association testing.
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The alternative approach called "Marker-level testing", is also a two-stage procedure, which reverses the order of variant-level testing. Since variant-level testing
presents a number of diculties, marker-level testing becomes an attractive alternative.

In the rst stage of marker-level testing, we carry out association testing at

the level of the single marker between raw intensity measurements and phenotype of
the null hypotheses "H0i : the

ith

marker is not associated with the

ith

phenotype".

Here intensity is a continuous measurement of copy number at every genetic marker.
Furthermore, we could get the association test results using a linear regression model
if the phenotype is also a continuous variable. Note that we do not involve specic
CNV calling in this step and thus we do not have to deal with diculties from "CNV
calling". The key point here is that, because the data is noisy, it is virtually impossible to identify CNV associations from a single marker. Since copy number variants
span over multiple markers in a suciently high-density array, the presence of a single CNV that aects the phenotype will elevate the test statistics for several nearby
markers. This is the motivation for the second stage of marker-level testing. To carry
out inferences regarding CNVs by pooling test results across neighboring markers to
determine CNV regions associated with the phenotype is the main job of stage II. By
conducting a multi-locus association test along the chromosome, combining neighboring

p-values,

we can detect a region for copy number-phenotype association with low

p-values in close proximity to each other marker.

It requires a systematic method for

pooling information across the neighboring hypothesis tests to identify the regions
in which low
approach on

p-values

p-values
p-values

are aggregated. In the dissertation, I develop a kernel based
to identify CNVs associated with a phenotype by aggregating

and show it has a well-controlled false positive rate and high power.

The negative log transformation of the
marker along a part of chromosome. The

p-values
p-values
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are shown in Figure 1.1 for every
are the results from the rst step
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Illustration of marker-level testing. The − log10 (p) values on each position along the partial chromosome based on the marker-level tests.

Figure 1.1:

of marker-level testing, which test associations between copy number intensity and
phenotype at every marker. From the plot, we spot the cluster of small
tween 102.5 and 102.7 Mb. This region with so many low

p-values

p-values

be-

in close proximity

to one another suggests an association between the phenotype and the copy number variation. In addition, marker-level testing, the main idea of which is illustrated
in the gure, avoids the complications of overlapping problems in variant-level testing.

Both of the above statistical technologies consist of two stages. This might result
in power loss in the second stage since those approaches risk losing information in the
the rst stage. The type of information lost by each approach is dierent and hence
it is strongly implicated for the power comparing between those two approaches. A
recent paper by Breheny et al., in which CBS was used for segmentation in both
approaches, demonstrates that variant-level testing has greater power to detect association involving large, rare CNVs while marker-level testing has more power to
detect small, common CNVs [35].
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1.4

Outline of the dissertation

The remainder of this thesis is organized as follows.

In Chapter 2, a kernel-based

aggregation of marker-level association test is developed in detail.

Since

p-values

between markers are correlated with each other, the exact distribution becomes complicated.

In the following 2 chapters, two dierent computational approaches are

proposed to overcome the diculty. I introduce a permutation procedure in chapter
3 and correlation method in chapter 4. In these two chapters, I also illustrate the
preservation of type one error and apply both approaches to both simulated and real
data. Finally, I summarize the results and discuss future directions in Chapter 5.

© Yinglei Li, 2014.

Copyright
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Chapter 2 Kernel-based Aggregation Method for Marker-level
Association Test

2.1

Introduction

Recent advances in genome, such as the completion of human genome sequence and
rapid improvements in SNP genotyping technology, have accelerated the process of
locating candidate genes. The development of statistical and computational strategies on hundreds of loci have investigated relationships between genome variation
and phenotypic variation. In spite of such advances, no comprehensive, well-powered
approach has been published to identify genes and loci that contribute to common disease. It has been receiving considerable attention to detect and locate CNV markers
over the past several years. Association test is broadly considered and highly accurate
to identify disease susceptibility genes related to complex disorder [36]. The choice of
association test is one of the main and important factors for a successful association
study. Before the emergence of large-scale association studies, many study of human
genetics has suered from the problem of inadequate statistical power, which results
in low rates of successful replication among reported signicant associations.

It is

always worthwhile to choose a good statistical method to maximize the statistical
power and preserve well-controlled false positive rate.

Genome-wide association studies (GWASs) were made feasible in the late 2000s.
Because of the enormous size of the data sets, GWASs have tended to use simple
statistical procedures for one gene at a time throughout the genome.

This single-

locus testing detects one gene at a time and is more suitable to study a susceptibility
gene with strong main eect on complex disorders. Evaluating one gene at a time
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focuses on its marginal eect on disease. Of course, there is no problem if focusing on
only one particular hypothesis. The marginal or individual

p-values

does not incor-

porate any information about the dependence structure between these

p-values.

As

many genes are being tested simultaneously, keeping the signicance threshold at the
conventional value of 0.05 would lead to a large number of false positive signicant
results.

Such classic nominal signicance-threshold framework is inappropriate for

such studies. For example, if
and

n = 100

α = 0.05 is the nominal signicance rate for one marker

independent markers are tested at the same time, then false-positive

results will be obtained at a frequency of

1 − (1 − α)n = 0.99.

It means that there

is a chance of greater than

99%

icantly related to disease.

This is obviously an unacceptable rate.

that one or more markers are shown to be signifSuch problem

involving multiple testing and its eect on the genomewide type I error is the subject
of a ongoing debate [37].

There have been proponents for an alternative approach

to multiple testing adjustments. The traditional and the most widely used method
is standard Bonferroni correction. The Bonferroni correction sets the critical signicance threshold at

α = 0.05,

α

divided by the number of tests. For example, with 20 tests and

you'd only reject a null hypothesis if the

p-value

is less than 0.0025. The

Bonferroni correction tends to be a bit too conservative. We calculate the probability
of observing at least one signicant result to be

0.0488

when assuming that all tests

are independent of each other. In practical applications, that is often not the case.
Depending on the correlation structure of the tests, the Bonferroni correction could
be extremely conservative, leading to a high rate of false negatives.

Identifying regions of genome or candidate genes that are correlated to contribute to
disease is diculty because complex traits presumably arise from multiple interacting
genes with rather small eect. As there are many susceptibility loci, each single gene
will have only a small eect and cannot easily be detected by single-locus method.
Therefore, it would be appropriate to consider and analyze sets of marker loci jointly
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for genomewide association analysis rather than marker-by-marker approach that
completely ignores the possible interactions between susceptibility genes. In recent
years, multi-locus method is widely used for association study to localize the diseaserelated genes [38] since a high density of markers and high-resolution microsatellite
maps are available. Investigating association between marker genotypes and disease
phenotypes for multiple markers will capture more information regarding the total
combined eects of all disease genes and therefore increase the statistical power for
disease gene detection compared to single-locus inference that analysing one locus at
a time. Researchers have developed dierent kinds of multi-locus association analysis. For instance, there are multi-factor dimensonality reduction (MDR) by Ritchie
et al. [39], statistic combination tests by Hoh et al. [38] and

p-value

combinations by

Zaykin et al. [4042].

Our research focuses on the
began with Fisher's product
(PPM) [43].

Later, other

p-value

p-value

p-value

p-value

cated product

p-value

combination

method or the sum of log scale of

p-values

combination methods such as the sum

method(SPM) [44] and the minimum
Then

combination methods.

p-value

p-value

method (MPM) [45] were developed.

truncation was introduced by Wilkinson [46] and extended into trun-

p-value

method [41, 47].

method [40] and recently the rank truncated product

p-value

There is no uniformly most powerful method of combining

values [40]. In this thesis, I am aimed to develop a new and modied

p-value

p-

combi-

nation method for powerful multi-locus association scans and apply it to large-scale
simulation studies and real data analysis.
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2.2

Kernel-based aggregation of marker-level association tests

I introduce a two-stage procedure for an association study to locate disease susceptibility CNVs related to complex traits. Let

n denote the sample size and J

total number of markers. Consider a study region that contains
positions. Here I use

i to index subjects and j

to denote the location of marker

j

J

denote the

markers at dierent

to index markers with positions

`j

used

along the chromosome. Suppose our analysis data

consist of a set of marker genotypes together with phenotypic trait values measured
on each individual

(X i , yi ), i = 1, 2, ...n,

where

number intensity of every marker for subject
Here

Xij

H0j :

and

yi

J

the

j th

are the copy

is the phenotype for subject

represents the intensity measurement for subject

stage, we conduct
sises

i

X i = (Xi1 , ..., XiJ )T

i

at marker

j.

i.

In the rst

association tests for every single locus under the null hypothe-

marker is not associated to the phenotype,

j = 1, ..., J .

I refer to

the location at which a test statistic is computed as an analysis point. Then a series
of

p-values

are calculated from the association test between intensity and phenotype

for every marker. The association from the single-locus tests is the marginal eect of
each locus in the genome ignoring inter-marker association. The key to detect CNV
is the detection of signicant association between phenotypic trait values and the
markers or intervals in a genetic map, which leads to the second stage.

In the second stage, a multi-locus association test combining multiple neighboring

p-values is performed.

Compared to single-locus tests, multi-locus tests may increase

testing power by including the combined eect of disease-associated loci and intermarker relationship. Consider a window with multiple markers. Dene the the central
marker as anchor locus, which is denoted as
disease genes. Let
considering

h

h

`0 .

The anchor marker is used to capture

denote bandwidth and construct a window by simultaneously

before and after the anchor. I apply a kernel-weighted moving average
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for each window across our study region. Sliding windows formed scanning the entire
study region. Scanning all loci from the starting marker to the end marker, the whole
study region will be divided into overlapping windows as we shift the anchor locus.
Within each window, consider the local average for anchor

`0 , the center of a window.

P
j tj Kh (`j , `0 )
,
T (`0 ) = P
j Kh (`j , `0 )
where

h,

tj = f (pj )

is a function of the

p-value

for marker

(2.1)

j.

The smoothing parameter

which denes the bandwidth of the kernel, controls the size of the neighborhood

around the center location

`0 .

Every marker within the window may contribute to

the identication of disease genes, and the extent of each marker contribution is considered by assigning proper weights to markers within a window. The kernel function

K

controls the weight given to every

marker

j

pj

in the neighborhood based on how far away

is along the chromosome from the target location

`0 .

The higher weights are

assigned to the markers closer to the anchor and lower eects for remote marker loci.
The smoothing parameter

h

meanwhile eects the bias-variance tradeo.

bandwidth will decrease variance by pooling

A larger

p-values among a boarder region but in-

troduce more bias because considering more extra test results beyond the boundary
of a CNV.

One could apply (2.1) at any arbitrary location
to a nite set of aggregations

{Tj }

`0 .

We restrict our consideration

from reasonable locations at which a marker is

present and the bandwidth does not exceed the borders of chromosome. Furthermore,
the transformation of
of

tj ,

p-values

is chosen such that low

p-values

leading to signicance testing based on the statistic

T = maxj {Tj }.

In this section, we describe in detail the choice of kernel

f (pj ),

produce large values

Kh

and transformation

as well as the issue of the direction of association for signed tests.
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2.2.1

Choice of kernel

In nonparametric analysis, the goal is to smooth the data in some way and estimate
a curve. Kernel-based approaches are an important class of smoothing methods. The
main idea behind the method is to assign location weight based on each observation
and then aggregate them to yield an overall local average. Additional details of this
method and its application to CNV association studies will be discussed here.

There are usually two primary choices with regard to the kernel: kernel function
and bandwidth selection. First, let's consider the shape of the kernel. Consider two
frequently used kernel density functions, at (boxcar) kernel and the Epanechnikov
kernel, are considered in our study:

Flat(boxcar)

Epanechnikov

: Kh (`j , `0 ) =

: Kh (`j , `0 ) =




1

|`j − `0 | ≤ h

if

(2.2)



0
otherwise
 

2 

`j −`0
3

 1−

if



0

otherwise

4

h

|`j − `0 | ≤ h
(2.3)

The Epanechnikov kernel would seem to be more attractive, as it gives higher
weight to markers close to the anchor location, and negligible weight to remote markers where bias is a larger concern.

Besides varying the shape of kernel, the quality of the kernel estimate depends
more on the denition of its bandwidth. Since the aggregation function (2.1) considers the weighted average of a few markers within the bandwidth of the center
marker, it would be interesting to consider two denitions of bandwidth, which we
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refer to as

constant width

constant marker

and

(these concepts are named metric

and adaptive bandwidths, respectively, in kernel smoothing literature). In the constant width approach, the width

h

of the kernel is constant in functions (2.2)-(2.3).

Meanwhile the number of markers for every kernel window varies the target location

`0

changes, thereby suering from uctuating variance.

In contrast, the constant

marker approach provides constant number of markers for each kernel window. But
meanwhile it produces various range of the kernel, thereby suering from bias. Specifically,

hk (`0 ) = |`0 − `[k] |,

location

`0 .

where

`[k]

is the location of the

k th closest marker to target

Simulation results regarding the benets and drawbacks of these various

kernels are shown in the next chapter.

As a matter of reference, the at, constant marker kernel is similar to the simple
moving average, although not exactly the same.

The boxcar kernel for constant

marker method assigns the same weight of 1 to the eective markers which are within
the

h

nearest neighbors to

`0

and assigns 0 otherwise.

For example, consider the

following illustration.

Suppose

1

2

3

4

5

6

●

●

●

●

●

●

h = 3.

We keep varying the target location,

`0

to get the aggregation for

each marker. Unlike the moving average, constant marker kernel looks for the nearest
neighborhood to the target location. For example, at
are

{p1 , p2 , p3 },

nations such as

while at

`4 ,

{p3 , p4 , p5 }

`3 ,

the three nearest neighbors

the three nearest neighbors are

{p4 , p5 , p6 }.

Thus, combi-

are not considered by the kernel approach. One obvious

benet of this method is to exclude the aggregation over inappropriately disperse
regions of the chromosome.
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2.2.2

Transformation of p-values

As suggested in (2.1), directly pooling p-values is not necessarily optimal. We consider
various transformations of
of

tj = f (pj )

p-values

in a way that low

and hence the statistic

T = maxj {Tj }

p-values

lead to high values

of association testing.

Such

transformations might better discriminate true association from noise. Three main
transformations, uniform, Gaussian, and logarithmic, are considered as follows:

p

:

tj = 1 − pj

(2.4)

Z

:

tj = Φ−1 (1 − pj )

(2.5)

log

:

tj = − log pj ,

(2.6)

where the text to the left of the equation is the label with which we will refer to these
transformations in later gures and tables.

As mentioned in Section 2.1, all these three transformations have a long history
in the eld of combining

p-values

methods. Ronald Fisher rst proposed the Fisher

combination test, which is based on the the average of
log of the product of the

p-values [48].

log p values or equivalently, the

An alternative procedure developed by Samuel

Stouer [49] depends on the sums of normal-transformed

p-values Zi = Φ−1 (1 − pi ).

Finally, (2.4) was studied and derived by Edgington [44]. Several other researchers
have followed upon and developed these methods [5053]. Throughout this thesis, the
majority of work will focus on these thee scales uniform, Gaussian, and logarithmic.
Each of these methods has its respective advantages and has proven practical and
valuable in dierent elds. There is no uniformly most powerful method of combining

p-values [40].

Comparisons of the uniform, Gaussian, and logarithmic transformations

by simulation are shown in the later chapter.
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In the

p-value

combination literatures, tests were assumed to be independent for

the convenience of theoretical development. However, this assumption is too stringent for many practical application.

If

p-values

within a window are statistically

dependent, a problem common to all of these methods is the diculty of determining
or approximating the distribution of test statistic under an appropriate null hypothesis. More recently, dierent computational algorithms have been proposed to generate
null distribution with dependent

p-values, such as permutation, bootstrap, and Monte

Carlo [54].

Moreover, since marker-level testing does association tests for every marker among
the chromosome rst and then locates the CNV, the borders of the CNVs are unknown, as is the appropriate set of

p-values

calculate many dierent combinations
and contain

p-values

{Tj },

to combine.

Consequently, we must

which yield partially overlapping sets

of the same markers in dierent combinations.

resulting test statistics

{Tj }

Clearly, the

will not be independent. This is a concern that must

be addressed for further studies. The implications of such concerns are addressed in
chapter 3 and 4.

2.2.3

Direction of association

In (2.1), the association test between intensity and phenotype at each marker, is unrestricted and could arise from any kind of association test. Some association tests
such as

χ2

z

tests and

tests and

F

t tests have a direction associated with them, while others such as

tests do not. If the direction is available along with the test, it is ad-

vantageous and valuable to incorporate this direction into the analysis of multi-locus
association tests as we will see in Section 3.4.

23

Let

sj

denote the direction of association at marker

j.

For example, in a case con-

trol study, if intensities are higher for cases than controls at marker

j,

then

sj = 1 .

Otherwise, at markers where CNV intensities are higher for controls than cases,

sj = −1.

The signs are arbitrary; their purpose is to reect the fact that switch-

ing directions of association are inconsistent with the biological mechanism being
studied  an underlying, latent CNV that aects both phenotype and intensity measures  and thus likely to be noise. Considering this direction should diminish noise
and thus improve CNV detection. I introduce here extensions of the transformations
presented in Section 2.2.2 that include the direction of association.

When

sj

is available, I adjust the three transformations from 2.2.2 as follows:

p

:

Z

:

log

:

tj = sj (1 − pj )


1 + sj (1 − pj )
−1
tj = Φ
2

(2.7)
(2.8)

tj = −sj log pj .

(2.9)

All of these transformations have the same eect as mentioned in Section 2.2.2: when

pj ≈ 0

and

sj = 1, tj  0;

tj ≈ 0

regardless of the value of

give an aggregate value
have low

2.2.4

p-values

when

T (`0 )

pj ≈ 0

sj .

and

sj = −1, tj  0;

and when

pj ≈ 1,

In other words, all the test results combine to

that is large in absolute value only if the test results

and are consistently in the same direction.

Summary

The kernel-based aggregation method described above provides a nice way to test for
CNVs associated with the phenotype.

First, we obtain a list of

p-values

for every

marker through multiple hypothesis tests. Then we combine and transform
to yield a nite set of aggregations

{Tj }.

p-values

The nal signicance testing is based on the
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statistic

T = maxj {Tj }.

mations of

p-values

Here as described above, dierent choices of kernel, transfor-

and the direction of association test will eect the statistic and

thus eect the test power. The power comparisons through dierent choice will be
presented in the later chapter through simulation.

To determine the signicance of
Since the

maxj {Tj }, we must estimate its null distribution.

p-values are not independent among markers, the estimate of the exact null

distribution gets complicated. In chapter 3 and 4, we propose two approaches  one
based on a permutation approach and the other based on estimating the correlation
structure directly  to give an estimate of the null distribution. Moreover, we apply
these approaches to the simulated and real data.

© Yinglei Li, 2014.

Copyright
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Chapter 3 Family Wise Error Rate Control for Permutation Method

3.1

Introduction

In genomics, especially genetic association studies, it is common for tens of thousands
of genes or genetic markers to be measured. For our marker-level association testing,
the rst step involves a large number of markers being testing simultaneously.

As

discussed in Section 2.1, multiple hypothesis testing is a common problem in such
genomewide association studies.

If one does not take the multiplicity of tests into

account, then the probability that some of the true null hypotheses are rejected by
chance alone may be unexpectedly large.

In our studies, it is of great interest to

determine the phenotype-associated CNV region that spans several markers in the
second step.

And we consider the test statistic containing a list of

window for signicant result.

p-values

in a

Thus such problem involving multiple testing arises

and should be considered and paid more attention since the decision is based on the
dependent structure of corresponding marginal

p-values.

Failure to consider the eects of multiple comparisons would result in an abundance of false positive results. To deal with the multiple testing problem, we must
extend the idea of type I error to acknowledge multiple testing. The traditional or
classical criterion for error control is the familywise error rate(FWER), which is dened as the probability of rejecting one or more true null hypothesis. A procedure is
said to control FWER in the strong sense if FWER control at level

α (F W ER ≤ α

) regardless of which subset of hypotheses is true. Similarly, if the FWER control at
level

α

only when all null hypothesis are true, it is dened to control FWER in the

weak sense. We are then

1−α

condent that there are no false discoveries among
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the rejected hypothesis.

Another alternative criterion for error control is the false

discovery rate(FDR), which is the expected proportion of falsely rejected hypotheses.
It was rst introduced by Benjamini and Hochberg when proposing a step-down procedure to control FDR for independent structures [55]. It was later shown that this
procedure also controls FDR for certain dependence structures [56]. FDR is equal to
FWER when all null hypotheses are true. When the vast majority of the null hypotheses are true, as the case in association studies, it is common to focus on FWER
for the sake of simplicity. However, it would more appealing to use FDR in situations
where there are a large number of false null hypotheses involved [57].

With a high density of markers, our test statistics as described are highly correlated for multiple testing. The assumption of independence among tests is strongly
violated. Many dierent computational approaches have been developed to overcome
this diculty.

One alternative approach is permutation testing approach [45, 58].

Permutation tests shue the phenotype values among subjects a number of times
and keep the order of genotype set to create permuted data sets that have random genotype-phenotype associations.

Monte Carlo procedure was proposed by

Zaykin [40] and a direct simulation approach was advised by Seaman and MüllerMyhsok [59]. Permutation resampling procedure was considered in this chapter since
it is traditional and popular.

The empirical joint distribution of the test statistics

using such permuted data serves as the reference null distribution to determine the
CNV-phenotype association.

In this chapter, I will describe the permutation method, which is applied to our
kernel-based aggregation of marker-level test. Then I will illustrate that this approach
controls FWER through simulation and proof. Applying such method through sim-
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ulation, I compare many aspects of the kernel-based aggregation association test
statistic.

3.2

Signicance testing and FWER control

3.2.1

Exchangeability

In any analysis that involves aggregating marker-level test results, we must be able
to detect and quantify the signicance of regions like those depicted in Figure 1.1.
This is not trivial, however. As we described in Section 2.2.2, The fact that

p-values

among markers within a window are statistically dependent greatly increases the difculty of estimating the exact null distribution. Thus this dependence introduces a
lack of exchangeability between test results, which complicates matters and causes
various naïve approaches to fail. In this section, I compare three approaches that I
tried during my research and illustrate the consequences of non-exchangeability in
testing the signicance of a region with a preponderance of low

p-values.

One approach, suggested in [35], is to use circular binary segmentation (CBS; implemented in the

R

package

DNAcopy).

This method aggregates neighboring

p-values

by calculating the two sample t-test statistic comparing the mean intensity of a given
region with that of the surrounding region. The signicance of this test statistic is
quantied by comparing it to the distribution of maximum test statistics obtained by
permuting the

{pj }

values [30, 31]. However, the main assumption of this approach

is that the test results

{pj }

are exchangeable which is the justication for permuting

them.
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Alternatively, we may use the kernel-based method described in Section 2.2.1 to
aggregate the neighboring test results, thereby obtaining
possible approach to generate the null distribution of

Tmax

Tmax = maxj {Tj }.

One

is to rely on Monte Carlo

integration based on the fact that, under the null hypothesis of no association, all

p-values

follow a uniform distribution. Thus, for any choice of transformation and

kernel in (2.1), we may generate an arbitrary number of
then yield independent draws

Tmax .

Then the estimate

(b)

{Tmax }B
b=1 .

F̂0

(b)

{Tmax }B
b=1

under the null and

from the null distribution function

F0

of

is obtained using the empirical CDF of those draws

Through this approach, we apply a test for the signicant presence of a

CNV-phenotype association through the calculation of
assumption here is that, under the null, the
and so are

{Tj }

p = 1 − F̂0 (Tmax ).

The crucial

p-values among markers are independent

{Tj }.

An alternative to generate the null distribution and quantify the signicance of

Tmax is the permutation approach that is proposed and described fully in Section 3.2.2.
By permuting the phenotype prior to aggregation of the marker-level tests, it creates
the independence between intensity and phenotype among markers for each permuting.

Thus, using the empirical CDF of an arbitrary number draws

would obtain the estimate

(b)

{Tmax }B
b=1 ,

we

F̂0 (Tmax ).

Consider a genomic region in which individuals may have a CNV. The purpose of
the analysis is to detect and locate such a CNV if it is associated with a particular
phenotype. Thus, the null hypothesis for our association test may hold in one of two
ways: (1, No CNV) no individuals with CNVs in that region are present in the sample, or (2, No association) individuals with CNVs are present in the sample, but the
CNV does not aect the disease and thus dose not change the probability of develop-
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ing the phenotype. The preservations of type I error of the three methods discussed
above under each type of null hypothesis is shown in Table 3.1. It demonstrates that
while all three methods have the proper type I error rate in the `No CNV setting,
only the permutation approach preserves the correct type I error in the case where a
CNV is present, but not associated with the disease (No association). It's easy to see
that

p-values

are independent for all methods under null hypothesis 1 (No CNV).

When a CNV is present but not related to the disease for null hypothesis 2 (No
association), it is still true that the marginal distribution of each

pj

is Uniform(0,1)

for each marker. This phenomenon is also illustrated graphically in Figure 3.1.

Table 3.1:

Preservation of Type I error for three methods with nominal

α = .05

in two possible settings for which the null hypothesis holds. The simulated genomic
region contained 200 markers, 30 of which were spanned by a CNV. The CNV was
present in either 0% or 50% of the samples, depending on the null hypothesis setting.
A detailed description of the simulation data is given in Section 3.4.
Circular

Kernel

Kernel

binary

Monte

Permutation

segmentation Carlo
No CNV

0.05

0.06

0.06

No Association

0.20

0.54

0.06

Table 3.1 and Figure 3.1 demonstrate that CBS and kernel Monte Carlo are not
guaranteed to preserve the type I error in all settings. Exchangeability is very crucial
to be considered when estimating the null distribution.

I also make the following

additional observations from comparison results: (1) The CBS approach is somewhat
more robust to the exchangeability issue than the Monte Carlo approach;

i.e.,

its

type I error rate is not as badly violated. (2) The data simulated here for the no
association setting are a little bit exaggerated: the CNV was present in 50% of the
population and the signal to noise ratio was about twice as high as that typically
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No CNV
Monte Carlo

0.0

0.0

0.2

0.4

0.6

No CNV
Permutation

0.8

1.0

0.0

0.4

0.6

p

p

No Association
Monte Carlo

No Association
Permutation

0.2

0.4

0.6

0.8

1.0

0.0

p

Figure 3.1:

0.2

0.2

0.4

0.6

0.8

1.0

0.8

1.0

p

Ability of Monte Carlo and Permutation approaches to maintain family-

wise error rate under the two null scenarios. The implementation of CBS provided
by

DNAcopy does not return p-values (only whether they fall above or below a cuto ),

and thus could not be included in this plot.

observed in real data.

In more realistic settings, the violation of type I error rate

will be not nearly as severe. (3) Circular binary segmentation was developed for the
purpose of detecting CNVs, not aggregating marker-level tests, and thus its failure to
preserve the family-wise error rate in this setting is in no way a criticism of CBS in
general.

3.2.2

Permutation approach

The concept of permutation tests was rst proposed by Fisher(1935).
provided an introduction to the theory of permutation testing.

Good(1994)

A summary of the

theory of permutation tests can be found in Lehmann (1986). Permutation tests are a

31

class of widely-applicable non-parametric tests. They use random shues of the data
to estimate the correct distribution of a test statistic under a null hypothesis. They
provide valid tests with the advertised Type I error, although they are more computationally intensive than standard statistical tests. Permutation tests are widely
used in genetics and genomics. They are especially useful when we have insucient
information about the distribution of the data, are uncomfortable making assumptions about the distribution, or if the distribution of the test statistic is not easily
computed. They are used in candidate-gene and genome-wide association studies, as
well as in family-based association tests.

In our case of CNV-association testing, a permutation test gives a simple way to
compute the sampling distribution for the test statistic, under the null hypothesis
that a set of genetic variants has absolutely no eect on the outcome. Permutation
involves randomly repeated "shuing" of the phenotype trait values and thus creates
many samples under the null hypothesis to estimate the sampling distribution of the
test statistics. I formally dene the kernel permutation method introduced in Section 3.2.1 and show that it preserves family-wise error rate for the problem of CNV
association testing. In this section below, I will fully describe this approach and prove
that it preserves type I error and controls FWER theoretically.

For a given set of test results

{pj }

and

tj = f (pj ),

consider the statistic

Tmax = max{Tj },
j

where

Tj

is the kernel-based aggregation of

available , with results

{pj , sj },

we use

tj

in a window. If signs of the tests are

Tmax = maxj {|Tj |}.
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(3.1)

To estimate the null distribution of
erating up to

n!

unique draws

(b)

Tmax ,

{Tmax }B
b=1

we use a permutation approach, gen-

from the permutation distribution of

Tmax .

The procedure is as follows. At any given iteration, draw a random vector of phenotypes

y (b)

by permuting the original vector of phenotypes. That is, reassigning each

phenotypic trait to a new individual while retaining the individual's genetic intensities. Under the null of no association between intensities and phenotypes, randomly
shuing the phenotypic values across individuals will not alter the distribution of the
test statistic. Next, carry out marker-level tests of association between the original
CNV intensities and the permuted vector of phenotypes, obtaining a vector of permutation test results

(b)

{pj }.

Section 2.2.1 to obtain

Finally, apply the kernel aggregation procedure described in

(b)

(b)

{Tj } and Tmax .

The entire procedure is repeated

B

times. In

this way, we reach the independence between intensities and phenotypes for each iteration such that all permutated results

(b)

{Tmax }B
b=1

are equally likely and exchangeable.

Computing appropriate test statistics from each shuing, we are essentially sampling
from a null distribution corresponding to no association between intensities and trait
values. We may then use the empirical CDF of these draws from the permutation
distribution of

Tmax

to obtain the estimate

F̂0 .

Thus, we obtain a global test for the

signicant presence of a CNV-phenotype association based on

p = 1 − F̂0 (Tmax ).

By

preserving the correlation structure of the original CNV intensities, this approach
does not rely on any assumptions of exchangeability or independence across neighboring markers, and is thereby able to preserve the type I error rate of the testing
procedure, unlike the other approaches described in Section 3.2.1.

I now formally

present this result, the proof of which appears as below.

Theorem 1.

Let H0 denote the hypothesis that the phenotype, yi , and the vector of

CNV intensities, xi , are independent. Then, using the permutation approach described
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above for any of the kernel aggregation approaches in Section 2.2.1, for any α ∈ (0, 1),
Pr(Type I error) ≤ α.

Proof of Theorem 1.
the CDF of

Tmax

P

Let

over

P,

Tmax (X, y) > F0−1 (1 − α)

(3.2)

denote the set of all possible permutations of

and

F0−1

its generalized inverse. Also, let

{yi }, F0

φ(X, y) = 1

if

and 0 otherwise.

Now, note that under the null hypothesis that

P (X, y) =

Y

=

Y

xi

and

yi

are independent,

P (xi , yi )

i

P (xi )P (yi )

i

= P (X, y∗ )
for all

y∗ ∈ P .

Thus,

E0 φ(X, y∗ )

is a constant for all

y∗

and

1 X
E0 φ(X, y∗ )
n! y∗ ∈P
1 X
φ(X, y∗ )
= E0
n! y∗ ∈P

E0 {φ(X, y)} =

≤ α,
where the term inside the expectation in the second line is less than or equal to
all

X

and

y

α

for

by the construction of the test.

The permutation test is guaranteed to have the correct desired false positive rate
(Type I error) regardless of the distributional characteristics of the data at hand. It is
worth pointing out that the above theorem is proven for the case in which all permutations of

{yi }

are considered. In practice, as it is usually impractical to consider all

permutations, one can generate only a random samples of these permutations from
the set of all permutations of the data. However, by the law of large numbers, the
above conclusion still holds approximately, and may be made as precise as necessary

34

by increasing the value of

B,

the number of permutations evaluated. For the numer-

ical results in Section 3.4, we use

B = 1, 000.

The global test above aims to quantify and represent compelling evidence for a
CNV-phenotype association among the whole chromosome. However, it is of limited
practical benet in the sense that it does not indicate the location of the associated
CNV. Thus, we could consider the following equivalent marker-level test: declare signicant evidence for the presence of a CNV-phenotype association at any marker for
which

Tj > F0−1 (1 − α).

Below, we state the corollary to Theorem 1 for the kernel

permutation method, viewed as a multiple testing procedure for each marker.

Corollary 1.

Let H0j denote the hypothesis that the phenotype, yi , and the CNV

intensity at marker j , Xij , are independent. Then, under the global null hypothesis
that yi is jointly independent of {Xij }, for any α ∈ (0, 1),
Pr(At least one Type I error) ≤ α

(3.3)

using the permutation approach described above and Tj > F0−1 (1 − α) as the test
function for H0j . In other words, the testing procedure described above controls the
FWER in the weak sense at level α.
It is worth noting that the procedure above controls the FWER only in the weak
sense  in other words, that it limits the probability of a false declaration of a CNV
only under the global null hypothesis that there are no CNVs associated with the
outcome. Typically in multiple testing scenarios, this is undesirable and strong control is necessary. However, in the case of CNV-phenotype association, strong control
is impractical, as it would imply that a method not only identies CNV-phenotype
associations, but can perfectly detect the genomic boundary of any associated CNV.
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This is an unrealistic requirement; in practice, there is no way to prevent the possibility that a detected CNV-phenotype association may spill over beyond the boundary
of the CNV.

3.3

Gemcitabine study

In this section we describe a pharmacogenomic study of gemcitabine, a commonly
used chemotherapeutic agent in many kinds of cancer.

I begin by describing the

design of the study [35], then analyze data from the study using the proposed kernelbased aggregation method by permutation.

This data will also be used to create

spike-in simulated data sets for power comparison of simulation studies in Section 3.4.

The gemcitabine study was carried out on the Human Variation Panel, a model
system consisting of cell lines derived from Caucasian, African-American and Han
Chinese-American subjects (Coriell Institute, Camden, NJ). Gemcitabine cytotoxicity assays were performed at eight drug dosages (1000, 100, 10, 1, 0.1, 0.01, 0.001,
and 0.0001 uM) [60]. Estimation of the phenotype IC50 (the eective dose that kills
50% of the cells) was then completed using a four parameter logistic model [61].
Marker intensity data for the cell lines was collected using the Illumina HumanHap
550K and HumanHap510S at the Genotyping Shared Resources at the Mayo Clinic
in Rochester, MN, which consists of a total of 1,055,048 markers [62, 63]. Raw data
were normalized according to the procedure outlined in [64].

172 cell lines (60 Caucasian, 53 African-American, 59 Han Chinese-American)
had both gemcitabine cytotoxicity measurements and genome-wide marker intensity
data. To illustrate the application of the kernel permutation approach, we selected
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one chromosome (chromosome 3) from the genome-wide data. To control for the possibility of population stratication, which can lead to spurious associations, we used
the method developed by [65], which uses a principal components analysis (PCA)
to adjust for stratication. At each marker, a linear regression model was t with
PCA-adjusted IC50 as the outcome and intensity at that marker as the explanatory
variable; these models produce the marker-level tests.

We analyzed these data using the kernel-based approach described in Section 2.2
with a bandwidth of 50 markers and the log transformation. The results are shown
in Figure 3.2. Note the presence of a peak at 102.6 Mb; this genomic region was also
illustrated in Figure 1.1. The red line indicates the FWER-controlled, chromosomewide signicance threshold at the

α = 0.1

level. As the gure indicates, there is in-

sucient evidence in this study to establish a CNV association involving response to
gemcitabine (p

= 0.16)

after controlling the chromosome-wide FWER. Other choices

of bandwidth and transformation produce qualitatively similar, although somewhat
less signicant, results.

Copy number variation in the region of chromosome 3 at 102.6 Mb, which is in
close proximity to the gene ZPLD1, has been found by [66] to be associated with
childhood obesity.

An earlier analysis of this data by [35] indicated suggestive ev-

idence that this region harbors a CNV association with gemcitabine response but
lacked a formal way to control the error rate at the chromosome-wide level.

This

example illustrates the need for the more rigorous approach we develop here. The
lack of signicance in this example is perhaps not surprising, in that 172 subjects is
a relatively small sample size for a CNV association study.
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Figure 3.2:

Analysis of the gemcitabine data (Chromosome 3) using the proposed

kernel aggregation method.
mosomal position.
signicance at the

3.4

The kernel aggregations

Tj

are plotted against chro-

The red line indicates the cuto for chromosome-wide FWER

α = .1

level.

Simulation

3.4.1

Spike-in data design

As illustrated, the permutation approach is a valid way to assess the signicance of
the proposed kernel-based CNV-phenotype association test.

In order to study the

power of the proposed approach to detect CNV-phenotype associations, we simulate
CNVs and their corresponding intensity measurements, LRR. The validity and accuracy of our conclusions rely on how realistic the simulated data is, so we need to put
careful thought into simulating this data in as realistic a manner as possible. Here in
the thesis, I use the spike-in design that is described in [35].

The basic design of our simulations is to use real data from the gemcitabine study
described in [35], spike a signal into it, then observe the frequency with which we
can recover that signal. We t a circular binary segmentation model [30, 31] to estimate underlying mean intensity for every marker along the chromosome. Then We
calculate the residuals by subtracting the actual intensity measurement from the es-
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timated mean. These residuals form a matrix representing measurement errors from
real data and we use these residuals to simulate our LRR noise. We pick chromosome
3 of the gemcitabine pharmacogenomic study for simulation and this residual matrix,
denoted

R,

has 172 rows (one for each cell line) and 70,542 columns (one for each

marker).

Our simulations involve short genomic regions containing 200 markers in which a
single CNV is either present or absent. The length of the CNV varies from 10 to 50
markers. We randomly select residuals from the above residual matrix to simulate
LRR noise over our study genomic regions. Then add in a signal. Letting
subjects and

j

denote markers, the following variables are generated:

for the presence or absence of a CNV in individual
at marker

j

for individual

i;

and

yi ,

i; xij ,

i

denote

zi , an indicator

the intensity measurement

the phenotype for subject

i.

We focus here on

a random sampling design in which the outcome is continuous. In the random sampling design, the CNV indicator,

γ = Pr(zi = 1)

zi , is generated from a Bernoulli distribution, where

is the frequency of the CNV in the population. Meanwhile,

generated from a normal distribution whose mean depends on

yi |zi

is

zi .

For each simulated data set of every subject, 200 markers were randomly selected
from the columns of

R.

The measurement error for simulated subject

i

was then

drawn from the observed measurement errors at those markers for a randomly chosen
row of

R.

The random selection of markers would remove the possibility of bias from

correlation among the intensities of neighboring markers. Thus, within a simulated
data set, all subjects are studied with respect to the same genetic markers, but the
markers vary from data set to data set. Simulating the data in this way results in
all the features of outliers, heavy-tailed distributions, skewness, unequal variability
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among markers, and unequal variability among subjects that are present in real data.

The intensity measurements

{xij }

,as mentioned, derive from these randomly ob-

served residuals in the real data. To the noise, we add a signal(mean structure) that
depends on the presence of the simulated CNV,

zi .

The added signal is equal to zero

unless the simulated CNV region; otherwise the added signal is equal to the standard
deviation of the measurement error times the signal to noise ratio. Thus, adding the
signal value to independent measurement errors, we generate our simulated intensities. Choosing an appropriate signal to noise ratio is less obvious. For the amount of
noise, the standard deviation of the residual values is 0.9. Signal, however, depends
on a number of unknown and poorly understood factors. We would simulate CNVs
with a signal of mean shift 0.72 and thus employed a signal to noise ratio of 0.8 for
simulation, which corresponded roughly to a medium-sized detectable signal based
on our inspection of the gemcitabine data. In such a construction, phenotype and
intensity measurement are conditionally independent given the latent copy-number

zi .

An illustration of the spike-in process is given in Figure 3.3.

2

3

status

●

●

●

●
●
●●

●
●
●
●
●
●
● ●● ● ●●●
●
●●
●
●
● ●●●
● ●
●
● ●
●
●
●
●
●
●
●
● ●●
●
●●
●
● ●●
●
●
●●
●●
●
●
●
●
●
●
● ●
● ● ●● ●●
●
●
●
●
●
●
●
●
●
●●
●
●
●●
●
●
●
●
● ●
●
●
●●
●
●
●
●
●
●
●
●
●

●

●
●

●

●

●

●●

●
●●
●
●●

●
●

●

●

●

●

●●
●
●●

●

●
●

●

●●
● ●
●
●
●

●

●
●
● ●
● ●

●

●

●

●

●

●

●●

●
●
●

●

●

●
●

●

●

●

●

●
●

●

●●

●
●

●
● ●
●
●

●

●

●
●
●

−2

●
●
●

●

●

●

−3

Figure 3.3:

●
●●
●
●●

●●

106.0

106.1

106.2

106.3

106.4

106.0

Position (Mb)

Illustration of spike-in simulation design.

●●
●

Right:

●●
● ●
●
●
●

●●
●

●

●

●
●
●

●

●
●

●

●
●

●
●

●
●
●
●
●

●

106.2

106.3

106.4

Position (Mb)

Left:

The resulting simulated data.
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drawn from among the estimated measurement errors for a single cell line.
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Using this procedure, the simulated data appears similar to the real data. For the
Illumina Human1M-Duo BeadChip, which has a median spacing of 1.5 kb between
markers, 200 markers corresponds to simulating a 300 kb genomic region. We varied
the length of the CNV from 10 to 50 markers, corresponding to a size range of 15 to 75
kb. For the simulations presented in the remainder of this section, we used a sample
size of

n = 1, 000 and an eect size (mean divided by standard deviation) of 0.4 for the

continuous outcome. All association tests are conducted with type I error rate of 0.05.

Using such simulation data, we compare the power while varying CNV sizes, transformations of

p-values

or kernels. For each setting, 1000 independent data sets are

generated and analyzed. Power is dened as the fraction of data sets in which CNVphenotype association is declared. The association test at each marker would derive
from a linear regression model between intensity and phenotype. One would prefer a
method that not only detects CNV associations but also identies their boundaries.
Here I focus only on detection of phenotype-associated CNV in my thesis.

3.4.2

Comparison of transformation

For the various transformations proposed in Sections 2.2.2 and 2.2.3 for dierent association tests, we evaluate the relative impacts of transformation and association
direction on power. First, we here set CNV frequency to be 10%. In order to isolate
the eect of transformation, we set bandwidth of the kernel to be the "optimal bandwidth", which is chosen to match the number of markers for the underlying CNV
and thus results in the maximum power to detect a CNV-phenotype association. In
practice this approach is not feasible since the size of the underlying CNV is unknown.
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Figure 3.4:

Eect of transformation choice and direction of association on power.

Population CNV frequency was set to 10%; optimal bandwidths used.

The results in Figure 3.4 demonstrate the impact of transformation choice on
power.

The gure illustrates a basic trend that held consistently over many CNV

frequencies and bandwidth choices. Various choices of transformation produce consistent results for both association test settings by comparing the left and right halves
of the gure. Furthermore, if the direction is available along with the test, all transformations by incorporating the direction of association perform much better than
ignoring the direction of association with regard to power. Besides, although various
transformations do not alter power dramatically, the normalizing transformation (Z)
is the most powerful for signed test results, while the log transformation obtains the
highest power for unsigned tests. In the results that follow, unless otherwise specied,
I employ the normalizing transformation for signed test results and the log transformation for unsigned tests.

3.4.3

Comparison of kernel choice

As illustrated in Section 2.2.1, there are two important factors with regards to kernel.
Thus here in this section, we examine two aspects of kernel choice: bandwidth imple-
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mentation (constant-width vs. constant-marker) and kernel shape (at vs. Epanechnikov). When all markers are equally spaced, the constant-width and constant-marker
kernels are equivalent. To evaluate the impact of bandwidth on power when markers
are unequally spaced, we selected at random a 200-marker sequence from chromosome
3 of the Illumina HumanHap 550K genotyping chip and spiked in CNVs of various
sizes. We specied ve bandwidth corresponding to window size varying from 10 to
50 markers.

The optimal bandwidth (either in terms of the number of markers or

base pairs spanned by the underlying CNV) was chosen for each method.
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Figure 3.5:

Eect of kernel choice on power.

constant-marker kernel.

Right:

40

50

Bandwidth

Left:

Constant-width kernel vs.

Flat vs. Epanechnikov kernel. In both plots, popula-

tion CNV frequency was 10%, test results were unsigned, and the log transformation
was used.

The left side of Figure 3.5 presents the results of this simulation comparing kernels with two dierent bandwidth implementations. The constant-marker approach
is substantially more powerful through all bandwidth settings. When the number of
markers within each window is not held constant, the aggregation measure
highly variable for some values of

Tmax

j

Tj

is more

than others. This causes the null distribution of

to have thicker tails, which in turn increases the
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p-value

for the observed

Tmax ,

thus lowering power. This phenomenon manifests itself most dramatically for small
bandwidths. Consequently, throughout the rest of this chapter, we employ constantmarker kernels for all analyses.

The right side of Figure 3.5 presents the results of comparing the kernel shape
between the at kernel described in (2.2) and the Epanechnikov kernel described in
(2.3).

We make several observations: (1) The shape of the kernel has only a lim-

ited eect on power; the performance of two dierent kernel functions with regard to
power seems similar. (2) The kernel approach is relatively robust to choice of bandwidth; even 5-fold dierences between the test bandwidth and optimal bandwidth do
not dramatically reduce power. (3) Nevertheless, the optimal bandwidth does indeed
perform best when the number of markers included in the kernel matches the true
number of markers spanned by the CNV. A larger window may include too many
non-informative markers and lead to a reduction in testing power; a smaller window
may ignore informative markers and thus decrease the power.

Thus, choosing dif-

ferent bandwidth would change the power. (4) The Epanechnikov kernel is slightly
more robust to choice of bandwidth than the at kernel is. This makes sense, as the
Epanechnikov kernel gives less weight to the periphery of the kernel.

3.4.4

Comparison of kernel-based aggregation and variant-level testing

Lastly, we compare the kernel-based aggregation approach with variant-level testing. To implement variant-level testing, each sample was assigned a group (variant
present or variant absent) on the basis of whether a CNV was detected by CBS.
A two-sample

t-test

was then carried out to test for association of the CNV with the

phenotype. This variant-level approach was compared with kernel-based aggregation

44

of marker-level testing for a variety of bandwidths. The results are presented in Figure 3.6.
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Figure 3.6:

Power comparison of variant-level testing (using CBS for CNV calling)

with marker-level testing (using kernel-based aggregation).

For rare CNVs (5% population frequency), the power of the variant-level approach
and the aggregated marker-level approach are comparable. However, for more common CNVs, the marker-level approach oers a substantial increase in power. For the
most part, this increase in power persists even when the bandwidth is misspecied.
Only when the bandwidth was too small (selecting a 10-marker bandwidth for a 50marker CNV) did the variant-level approach surpass marker-level aggregation.

Generally speaking, these results are consistent with the ndings reported in [35],
who found that variant-level tests have optimal power relative to marker-level tests
when CNVs are large and rare; conversely, marker-level tests have optimal power relative to variant-level tests when CNVs are small and common. This is understandable
given the limited accuracy of calling algorithms for small CNVs.
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Comparing the results in Figure 3.6 with the results of Breheny et al. [35], who
aggregated marker-level tests by applying CBS to the

p-values

as described in Sec-

tion 3.2.1, we nd that the kernel approach is a substantially more powerful method
for aggregating marker-level tests than a change-point approach. Specically, Breheny

et al.

found that the change-point approach had very low power at 5% frequency 

much lower than the variant-level approach. On the other hand, in the same setting
we nd that the kernel approach is comparable to, and even slightly more powerful than, the variant-level approach.

Furthermore, as discussed in Section 3.2.1, a

change-point analysis of marker-level tests also relies on exchangeability, which does
not always hold.

Thus, the methods developed here in the thesis are both more

powerful and achieve better control over the FWER than the change-point analysis
described in [35].

A potential drawback of the kernel approach is the need to specify a bandwidth.
This makes the robustness of the method to bandwidth misspecication, as illustrated
in Figure 3.6, particularly important because in practice it is dicult to correctly
specify the bandwidth

a priori.

Indeed, it is possible that multiple CNVs associated

with the outcome are present on the same chromosome and have dierent lengths.
A method that is not robust to bandwidth would be incapable of detecting CNVs.
Generally speaking, a bandwidth of roughly 30 markers seems to provide good power
over the range of CNV sizes that we investigate here.

© Yinglei Li, 2014.

Copyright
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Chapter 4 Correlation Method and Its Family Wise Error Rate Control

4.1

Introduction

I introduced kernel-based aggregation method to determine the CNV-phenotype association. As

p-values

are correlated with each other among markers, it is complicated

to estimate the exact null distribution when applying the method. There is no specic
computational approaches developed to estimate the null distribution when applying the kernel-based method. I applied a permutation procedure to our kernel-based
framework in Chapter 3. I demonstrated that this method provides evidence of association between phenotype and genotype while preserving accurate FWER. However,
the permutation approach has its own limitations as mentioned earlier. One important drawback for analysis is the computational burden of the method. For simple
tests such as the linear regression tests we used in the gemcitabine study, the burden
is quite manageable.

On our machine (using an Intel Xeon 3.6 GHz processor), it

takes under a second to perform the 70,542 marker-level tests on chromosome 3 and
under 0.1 seconds to perform the kernel aggregation. Carrying out 1,000 permutation
tests took 1,000 times longer: 15 minutes to carry out all the permutation tests and
21 seconds to perform all the kernel aggregation. Extrapolating a genome-wide analysis would take 3.5 hours. These calculations, however, are for simple marker-level
tests and a fairly small sample size (n
putation burden linearly (

i.e.,

= 172).

Larger studies will increase the com-

doubling the subjects should double the computing

time), but more complicated marker-level tests based on nonlinear, mixed-eects, or
mixture models would require substantially more time. But it is worth pointing out
that kernel aggregation itself does not consume time but the estimation of the null
distribution. As seen in Figure 3.2, the black dots may be calculated rapidly; the red
line is what requires the permutation testing. It is worth further research to discover
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ways to speed up the approach.

Since

p-values are statistically dependent,

correlation structure of

p-values.

the exact null distribution relies on the

In this chapter, a correlation-based approach with a

model-based formulation that avoids the need for permutation testing was considered
to apply to our kernel-based method in order to speed up the analysis.

I present

and demonstrate the procedure in details to approximate the joint distribution of the
test statistics. I show through simulations that this approach not only provides an
accurate error control, but also is much faster than the permutation approach.

4.2

Basic idea about correlation method

4.2.1

Correlation approach

Applying kernel-based aggregation of marker-level association test, we consider a twostage procedure. From association testings for every marker, we obtain a set of test
results

{pj }.

Then, when considering quantifying whether or not the data represent

compelling evidence for a CNV-phenotype association we use the statistic

Tmax = max{Tj },

(4.1)

j

where

Tj

is the kernel-based aggregation of

directional, with results

{pj , sj },

we use

To obtain the null distribution of

p-values

in a window.

If the tests are

Tmax = maxj {|Tj |}.

Tmax ,

we present an alternative to the permuta-

tion approach, which is a correlation-based procedure. We now formally present this
procedure to t our kernel-based aggregation framework as follows and show that it
preserves the family-wise error rate for the problem of CNV association testing.
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Step 1: Estimate a correlation matrix Σ that denes the relationship among z statistics under null.

First of all, we assume that the correlation completely describes

the dependence between the series of
Cholesky decomposition,

Σ = CC T ,

lation of the series of original

z -statistics.

is positive denite, then the

can be obtained. In many situations, the corre-

p-values

will later give details of calculating

Σ

If

is complicated to estimate from real data. I

Σ̂ for the CNV-phenotype association study under

assumption of simple linear model.

Step 2: Generate vectors of dependent z -values mimicking the original z -values from
the real data.

Geometrically, a symmetric and positive denite matrix

form uncorrelated variables to dependent
dom vector
where

Φ(.)

U

z -values.

C

will trans-

According to [40], generate a ran-

from independent uniform (0,1) distribution and let

Z = Φ−1 (1 − U )

was the cumulative distribution function of a standard normal random

variable. Given a random vector of i.i.d uncorrelated standard normal variables
the Cholesky transformation maps the variables
matrix

V ar(CZ) = CV ar(Z)C T = CIC T = Σ.

Z

into variables

Thus,

CZ

CZ

Z,

with covariance

reects the distribution of

test statistic under null that there is no association between genotype and phenotype.

Step 3: Construction of empirical null distribution of the test statistic.
multivariate normal distribution

CZ

Based on the

described in Step 2, we could create series of test

statistics from such distribution. If the direction of association is available, we could
calculate

p-values for both signed and unsigned cases.

arbitrary number of vectors of dependent

In this way, we may generate an

p-values among markers.

It is computation-

ally less demanding since it does not involve repeated analysis of simulated datasets.
For each vector of dependent

p-values

for the

bth

Monte Carlo sample, we calculate

the proposed test statistic applying kernel-based method to yield
for any choice of transformation and kernel in (2.1).

49

(b)

{Tmax , b = 1, ..., B}

Finally, we use the empirical

CDF of those draws to obtain the estimate

F̂0 =

(b)

P

I[Tmax ≤ x]/B .

1≤b≤B

Step 4: The calculation of the empirical overall p-value.

By the estimation of null

distribution function in Step 3, we obtain a test for the presence of a CNV-phenotype
association based on

4.2.2

p = 1 − F̂0 (Tmax ).

Replacing correlation among

z

statistics with correlation of inten-

sities
It is worthy to point out that this approach depends on the estimation of correlation
matrix of

z -statistic

under null. But it is always complicated to estimate. Suppose

our analysis data consist of a set of marker genotypes together with phenotypic trait
values measured on each individual

(X i , yi ), i = 1, 2, ...n,

where

X i = (Xi1 , ..., XiJ )T
i

is a vector of the copy number intensities for every marker for subject
phenotype for subject
phenotype

y

i.

Assume simple linear regression

as the outcome and intensity

able for every marker, where
deviation

σ.



xj

j th

y = β0 + β1j xj + 

x0ij

and

xij − x¯j = x0ij sdxij

is the

between

and

0

and standard

yi − ȳ = yi0 sdyi ,

yi0 .

Under the simple linear regression model, we have the

Zj =

yi

marker as the explanatory vari-

has a normal distribution with mean

By standardization, we dene

where we denote standardized

at

and

z -statistics

βˆ1j − 0
s.e.
P

(xij −x¯j )(yi −ȳ)
P
(xij −x¯j )2

= p P
σ̂ 1/ (xij − x¯j )2
P
sdxij x0ij sdyi yi0 q
=
(n − 1)sd2xij
σ̂(n − 1)sd2xij
P 0 0
xij yi
=p
,
(n − 1)
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under

H0 :

where

P
(xij − x¯j )2 = (n − 1)sd2xij

Now, correlation between

z

and also

σ̂ = sdyi .

statistics of any two markers is simplied and we get

P 0 0
P 0 0
xij yi
x y
, p ik i )
cor(zj , zk ) = cor( p
(n − 1)
(n − 1)
X
X
x0ik yi0 )
= cor(
x0ij yi0 ,
X
X
= cor(
x0ij ,
x0ik ),
since under the null hypothesis that

xij

and

yi

are independent.

Therefore,

X
X
cor(zj , zk ) = cor(
x0ij ,
x0ik )
= cor(xj , xk )
We summarize and present the following theorem.

Theorem 2.

Assume a simple linear regression model was t at each marker between

phenotype and genotype. Let H0j denote the hypothesis that the phenotype, yi , and
the CNV intensity at marker j , Xij , are independent. Then, under the global null
hypothesis H0 that yi is jointly independent of {Xij }, correlation structure among
z statistics under H0 exactly equals the correlation matrix of the intensities among

markers under assumption of simple linear model.
By Theorem 2, the correlation structure among

z -values

under

H0

is the same

as the correlation matrix of the intensities under assumption of simple linear model
between intensities and phenotypes for every marker.
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It is worth to note that the

estimate of correlation structure might depend on the knowledge of model assumption between intensities and phenotype.

Then we need the fact that correlation is

approximately invariant under monotone transformations [40]:

[g 0 (µ)]2 Cov(Xi , Xj )
= Cor(Xi , Xj )
Cor(g(Xi ), g(Xj )) ≈ p
[g 0 (µ)]4 V ar(Xi )V ar(Xj )

(4.2)

For some modelings like logistic regression, the z-value is a monotone function of
z-value of linear regression. Applying (4.2), their correlation should be more or less
equivalent.

Thus, we could extend to some other model assumption between phe-

notype and genotype by (4.2). If the

z -values

for some model assumption is highly

monotone in comparison with linear regression, we could get approximately the same
correlation estimate as the estimate under linear modeling.

4.2.3

Estimate of correlation matrix of intensities among markers

Theorem 2 provides a good way to estimate the correlation structure of

z -statistic.

Given the structure of intensities among markers, we could use the sample correlation
of intensities to estimate the correlation matrix of

z -statistic

under null hypothesis

of no CNV-phenotype association. But estimation of correlation matrix and application of such approach would be easy to achieve and would be well-applied when the
number of features is small. When the number of markers is large, it would cause
problems. First of all, the high dimensions

J ×J

matrix calculation will bring sta-

tistically eciency and computational problem. It always increases the computation
burden and might run out of memory for high dimensions. Besides, the algorithm in
section 4.2.1 requires Cholesky decomposition, which gets slower for high dimension
matrix. Hence, estimation of large-scale covariance matrix from real genomic data
become an ubiquitous problem. There are a lot of methods proposed in the literatures
for estimation under such case, including the spectral decomposition, Bayesian meth-
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ods, modeling the matrix-logarithm, nonparametric smoothing, and banding/thresholding techniques [6773].

It would be important to extend our research to high dimension, which is the typical situation in real data. Therefore, I develop dierent approaches to estimate the
restricted correlation matrix for computation convenience in dierent circumstances
for high dimensions of features. I will talk about it in the following sections.

4.3

Extending correlation approach to small

n,

large

J

setting

For genomics and transcriptome analysis, estimation of large-scale covariance or correlation matrices is a common problem. From a microarray experiment or CNV data,

J

markers are being analyzed with

a correlation of size

J ×J

J

perhaps in the order of 1,000 to 10,000 and thus

has to be calculated.

For analysis involving real data,

we do not know where CNVs are located before analysis. We normally collect more
and more intensity data that might include the possible CNV to detect the CNVphenotype association and detect the CNV location.

Hence, it is pretty common

to involve thousands or millions of markers from part of or the whole chromosome.
Meanwhile, it often encounters with a limited number of samples

n.

A common key

problem for all such data is that how we should obtain an accurate and reliable estimate of the population covariance matrix when a data set includes a large number of
variables but only contains comparatively few samples (n

n,

large

J

<< J ).

Under such small

setting, singular value decomposition (SVD) and principal component

analysis (PCA)are valuable tools and common techniques for analysis of such multivariate data.
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Principal component analysis (PCA) (Jollie 1986) is a popular data-processing
and dimension-reduction technique for taking high-dimensional data, and using the
dependencies between the variables to represent it in a more tractable, lower-dimensional
form, without losing too much information. It is a widely used mathematical tool for
high dimension data analysis. PCA provides a guideline for how to reduce a complex
data set to one of lower dimensionality to reveal any hidden, simplied structures
that may underlie it. It extracts the most important information in such a way as
to highlight their similarities and dierences from the data table and compress the
size of the data set by keeping only this important information. Then it can simplify
the description of the data set and analyze the structure of the observations and
the variables. The other main advantage of PCA is that once you have found these
patterns in the data, and you compress the data, ie. by reducing the number of dimensions, without much loss of information. Overall, PCA is one of the simplest and
most robust ways capable of reducing dimensions and revealing relationships among
data items. It has been applied in numerous elds such as engineering, biology, and
social science. Some interesting examples include handwritten zip code classication
(Hastie,Tibshirani, and Friedman 2001) and human face recognition (Hancock, Burton, and Bruce 1996). Recently PCA has been used in gene expression data analysis
(Alter, Brown, and Botstein 2000). Hastie et al. (2000) proposed the so-called gene
shaving techniques using PCA to cluster highly variable and coherent genes in microarray datasets. Strictly speaking, singular value decomposition is a matrix algebra
trick which is used in the most common algorithm for PCA. PCA can be computed
via the singular value decomposition(SVD) of the data matrix.

According to Theorem 2, correlation structure among

z -statistics Σ

exactly equals the correlation matrix of the intensities among markers.

n×J

original intensity matrix, where

n

is the sample size and
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J

under

H0

X

be

Let

is the number of

total markers. Applying SVD method on it, the singular value decomposition of
is the factorization of

X

into the product of three matrices,

X = U DV T ,
where
with

U

is

n×n

V T V = I.

denote the

n×J

j th

orthogonal matrix with

We could partition

U = (u1 , ..., un )

left singular vector and

σ1 , σ2 , ..., σr

Here

(4.3)

U T U = I, V

vj

denote the

diagonal matrix with diagonal entries

σr ) ≥ 0.

X

J ×J

is

and

j th

orthogonal matrix

V = (v1 , ..., vJ ),

where

D

right singular vector.

uj
is

(D11 = σ1 ) ≥ (D22 = σ2 ) ≥ ... ≥ (Drr =

are called the singular values.

The singular values are

sorted from high to low, with the highest singular value in the upper left index of the
matrix. If

rank(X) = r,

then it equals to the number of non-zero singular values on

the diagonal. Also, the column space of

X

n−r

columns of

U

is spanned by the rst

r

the last

last

J −r

where

XT

columns of

X

is spanned by the rst

span the null space of
columns of

V

XT .

r

columns of

U

and

Meanwhile, the row space of

and the null space of

X

is spanned by the

V.

X T X = (U DV T )T U DV T = V DU T U DV T = V D2 V T ,

(4.4)

XX T = U DV T (U DV T )T = U DV T V DU T = U D2 U T ,

(4.5)

is the conjugate transpose of

X.

The right hand sides of these relations de-

scribe the eigenvalue decompositions of the left hand sides. Consequently, the squares
of the non-zero singular values of

XX T

or

XT X.

Thus

eigenvalues when
The columns of

XT X

XX T

n<J

V,

X

which is

are equal to the nonzero eigenvalues of either

n×n

and the remaining

and

XT X

J −n

which is

J ×J

will share

eigenvalues of

XT X

will be zero.

n

which are called right singular vectors, are the eigenvectors of

and the columns of

U

,called left singular vectors, are eigenvectors of
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XX T .

Either the singular vectors of the singular values (or both) are called principle components. The matrix
matrix

X,

D

does not have to be square. Note that for a square, symmetric

singular value decomposition is equivalent to diagonalization, or solution

of the eigenvalue problem. SVD decomposes a matrix into a set of rotation and scale
matrices, which is used in computing the pseudoinverse, matrix approximation, and
determining the rank, range and null space of a matrix.


Let



σ1

Dr = 



..

.

σr



,



and hence (4.3) will become


X=

Ur Un−r


using

Ur =






T
Dr 0  Vr 
T
 = Ur Dr Vr ,


T
VJ−r
0 0



u1 · · · ur


and

Vr =

the ordinary SVD. Applying (4.6), any
a column-orthogonal

n×r

(4.6)



v1 · · · vr
n×J

. This thin SVD is equivalent to

real matrix equivalent to the product of

matrix, a diagonal

r×r

in descending order, and a column-orthonormal

matrix where the elements sorted

J ×r matrix.

It is a useful result since

we could reduce the dimension of the ordinary large matrix into product of simplied
matrix. In small

n,

such a large matrix

min(n, J) = n.
thin SVD of

large

X,

J

setting, the number of the non-zero singular values of

which equals the rank of

X,

would be smaller or equals to

If we know the rank of the intensity matrix to be

X.

r,

we could get the

Thus, applying such procedure, we could deal with smaller matrix

with the optimal low rank instead of the large matrix.

For calculating the covariance matrix of intensities, there is a direct relation between PCA and SVD in the case where principal components are calculated from the
covariance matrix. For PCA to work properly, the rst step in PCA is to move the
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origin to mean of the data. In our case, we could achieve the rst step by nding
means of every marker by averaging the columns of

X.

We then subtract the mean

intensity from each intensity of the data set (ie each row of

X ) to create the mean cen-

tered data vector. This produces a data set whose mean is zero for every marker. It
is very easy to compute the covariance matrix from the mean centered data matrix.
Furthermore, we apply the method to the correlation rather than the covariances.
For correlation matrix, the o-diagonal elements are on the same scale.

Also, the

correlations derived from covariance estimator are independent of scale and location
transformations of the underlying data matrix. Due to such distinct advantages, it is
better to work on correlation matrix, which we denote

Σ.

To achieve the correlation

matrix, we need to standardize the original data matrix. For every element of the
data matrix

xij ,

we apply the standardization.

x0ij =
where
for

X̄j

j th

and

sXj

xij − X̄j
,
sXj

(4.7)

are mean and sample standard deviation of

j th

column intensities

marker. For the standardized data matrix which we denote as

X

, we could

get the sample correlation matrix.

Σ=

1
(
n−1

X X)
T

(4.8)

Applying equation (4.6), here the sample correlation matrix would be

Σ=

1
(
n−1

The diagonalization of

X X) = n −1 1 (V D V
T

XX
T

2

yields

V,

T

)=

1
(Vr Dr2 VrT )
n−1

(4.9)

which also yields the principal components of

correlation matrix. So, the right singular vectors

vk

are the same as the principal com-

ponents of correlation matrix. Using the decomposition above, we can identify the
eigenvectors and eigenvalues for
elements of

D,

XX
T

as the columns of

V

and the squared diagonal

respectively. Clearly, the eigenvalues and eigenvectors of correlation
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matrix is the same as the eigenvalues and eigenvectors of
ter shows that the eigenvalues of

XX
T

XX
T

. Meanwhile, the lat-

must be non-negative. Therefore, the sample

correlation matrix here is positive semi-denite.

It is a common setting to have much more markers than samples,

n  J.

The

J ×J

correlation matrix itself is therefore very unpleasant to work with because it is very
large under small

n,

large

J

setting. However, by Theorem 2, it suces to decom-

pose a smaller matrix. In such setting, it is known that
which is

J ×J

will share

n

XX

eigenvalues and the remaining

T

which is

J −n

n×n and

eigenvalues of

XX
XX
T

T

are all zeros. Therefore, for the eigenvalues which are zeros, we can essentially discard
those eigenvalues and the corresponding eigenvectors, hence reducing the dimensionality of the new basis. Instead of dealing with
the smaller matrix with dimensions
mation since the other

J −n

J ×J

matrix for

Σ,

we could focus on

n × n for correlation matrix without losing infor-

dimensions don't contain any additional information.

It will be an amazing improvement in speed of computing the estimated correlation
matrix. For example, for a

70, 000 × 70, 000

174 × 70, 000 intensity matrix, we don't need to work with

correlation matrix, which we might not be able to store in our com-

puters. Instead, by the decomposition, the

174 × 174

matrix, which is a lot faster to

obtain, is enough to estimate the correlation matrix. It's really a great result that the
estimation of correlation matrix has nothing to do with the large

J

dimensions but

instead only depends on sample size for the matrix dimension. Thus, the smaller

n

is, the much faster to estimate the correlation matrix of intensities. For standardized
intensities

X

, the correlation matrix is equivalent to the variance-covariance matrix.

It is worthy to notice that the rank of the variance-covariance matrix is
correlation matrix only has a rank of

n−1

n

while the

since it is restricted to have 1's along

the diagonal. Therefore, following the above equation (4.9), we obtain the estimated
correlation matrix

1
(V
n−1

D2 V T ) and it is equivalent to
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1
V D2 V T in a much smaller
n−1 r r r

dimensions, where

r = n−1.

we only need to know the rst

n−1 left singular vectors.

Meanwhile, the decomposition has nothing to do with the right singular vectors
Thus, we could reduce the dimensions a lot and only select

uk .

n−1 vectors for calculation

of the correlation matrix. Obviously, the correlation matrix is obtained in a much
faster speed. As here the correlation matrix is positive semi-denite, we can denote

Σ = CC T .

By decomposition,C

=

1
(V
sqrt(n−1)

i.i.d uncorrelated standard normal variables
normal distribution with covariance matrix

DV T ).
Z,

Thus, given a random vector of

variables

CZ

follows a multivariate

V ar(CZ) = CV ar(Z)C T = CIC T = Σ.

This method works especially well for small

n,

large

J

setting.

The small

n

makes dimension reduction for calculating correlation matrix and hence speed it up
a lot compared to directly estimating the large correlation matrix. The comparisons
of performance will be shown in the later sections.

4.4

Extending correlation approach to large

n,

large

J

setting

There is a computation burden problem to estimate the high-dimensions correlation
matrix and use such large correlation matrix to generate the multivariate normal
random variables under null hypothesis. The time consumption increases as the dimension increases. I have proposed SVD decomposition method for the case of small

n,

large

J ,

which leads to the dimension reduction. Thus, we only need to deal with

low-dimensional matrix with dimension depending on the small
correlation matrix. However, this method is insucient when

n

n

to estimate the

gets large. Instead,

we hope to impose a low-dimensional structure on the estimator and aim to get a
sparse correlation matrix to decrease the computation burden. Such sparse correlation matrix gets rid of part of correlation information by setting them to be zero.
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Hence it would not be positive-denite any more. We have to additionally shrinkage this sparse matrix to be positive-denite for further generation of multivariate
normal vectors for large

n,

large

J

setting. Actually, it is pretty diculty to get a

sparse and positive-denite estimated correlation matrix to accurately estimate the
population correlation matrix among genes. I tried a couple of ways and luckily nd
out an appropriate method to estimate the true correlation matrix under large
large

J

n,

setting.

Biologically, the correlation between any two markers is a decreasing function of
distance. In other word, two nearby markers would be more highly correlated than
two markers far apart.

If two markers are far enough apart, we may ignore their

correlation by considering it to be zero. Setting those small correlations to be zeros,
we could restrict the correlation matrix to be a banded correlation matrix instead of
calculating every correlation entry. Such a sparse correlation matrix would improve
the eciency for computation under high dimensions of markers. On one hand, there
is a storage format for sparse matrix that stores only the nonzero entries in column
order and hence avoid the storage of the zero entries.
memory to store the matrix.

Thus it requires much less

Moreover, the computation focuses on the numerical

values of the nonzero entries so as to reduce memory usage and avoid unnecessary numerical operations. In this way, calculations based on sparse matrixes would provide
a signicantly higher calculation eciency. What's important, it is worthy to notice
that such banded sparse correlation matrix contains most of important correlation
entries without losing much information.

Here Figure 4.1 is a lled contour plot of sample correlation matrix under null
for 200 markers with the middle CNV size=30 for 10000 subjects and signal-to-noise
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Figure 4.1:

This is the sample correlation matrix. Red values are high correlation;

the only legitimate correlations are located in the CNV. The rest is just noise.

ratio=2.

In this plot, the red square with high correlations focus on the middle CNV markers while noise smaller correlations are surrounding for the rest markers far apart.
Hence, it would be applicable and reasonable to ignore those noise and set those
correlations to be zeros. Instead, we could just give an estimate of middle banded
correlations for the neighboring markers as the estimate of a huge correlation matrix.
Including the whole red part, we would not lose much information and get the estimate more accurate and close to the true correlation. Dene

61

d

to be the number

of diagonals we calculate the pairwise correlation for the sparse matrix.
would eect the estimate of banded matrix.

d

choosing

If using the true CNV size as

d,

the

estimated sparse correlation matrix would be the following plot Figure 4.2 and it
contains the whole central correlation of the sample correlation.

Figure 4.2:

This is sparse matrix with

d = 30

on both sides. It has the same central

banded correlation with the rest correlations equal to zero.

But if choosing a dierent

d,

the estimate would be very dierent.

As seen in

Figure 4.3, the estimate loses a lot of important correlations when choosing half of
the true CNV size.
From the above demonstration, we must keep the central main correlation part to
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Figure 4.3:

It is also a sparse estimate of correlation matrix with

d = 15

on each

side. The important part of the correlation was chopped o.

estimate the true correlation matrix accurately. To keep the central high correlation
part of the sample correlation matrix, it would be best to choose

d

at least equal to

the CNV size for the sparse matrix. Otherwise, the estimation would lose a lot of
important correlation information and hence gets far away from the whole sample
correlation.

However, this sparse estimate would cause singular problems. Such sparse banded
correlation matrix might not be positive denite any more. A naive strategy to obtain a positive denite estimator of covariance proposed by Rebonato (1999) runs
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as follows: take the sample covariance and decompose the covariance matrix into its
eigenvectors and eigenvalues, set the negative eigenvalues to 0 or (0

+ ),

and then

rebuild the covariance matrix. Higham (2001) uses an optimization procedure to nd
the nearest correlation matrix that is positive semi-denite.

Grubisic and Pietersz

(2003) have a geometric method they claim outperforms the Higham technique. Incidentally, some more recent twists on Rebonato's paper are Kercheval (2009) and
Rapisardo (2006) who build o of Rebonato with a geometric approach. They also
proposed several algorithms for computation to nd its nearest correlation matrix.
However, such nearest positive denite covariance matrix could not be sparse and
thus it is computationally by far demanding for the very large dimensions commonly
encountered in genomics problems. Therefore, we aim to keep the estimate of correlation matrix symmetric positive denite and sparse so that it will be a covariance
matrix of further multivariate normal distribution and meanwhile reduce the computation burden.

Special care should be taken in the construction of algorithms that create a large
symmetric sparse positive denite correlation matrix with the goal of reducing computation time and memory usage. I present shrinkage strategy here to create such
sparse positive denite large-scale correlation matrix.

4.4.1

Introduction to shrinkage approach

A fundamental principle of statistical decision theory is that there exists an interior
optimum in the trade-o between bias and estimation error. We could shrinkage the
unbiased estimator full of estimation error towards a xed target represented by the
biased estimator. Stein(1956) showed that shrinking sample means towards a con-
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stant would, under certain circumstances, improve accuracy. In the case of estimated
unbiased sample covariance matrix, those estimated coecients that are extremely
high tend to contain a lot of positive error and therefore need to be pulled downwards
to compensate for that. Similarly, we compensate for the negative error that tends
to be embedded inside extremely low estimated coecients by pulling them upwards.
We call this the shrinkage of the extremes towards the center to increase the accuracy.

Consider the well-known bias-variance decomposition of the mean square error
(MSE) for the sample covariance, i.e.

M SE(S) = Bias(S)2 + V ar(S).

obtain an improved covariance estimator is variance reduction.

We could

Here we propose

shrinking or more general biased estimation as a means of variance reduction of
sample covariance matrix. If properly implemented, this shrinkage would clearly x
the problem of the sample covariance matrix described above to be positive denite
and well-conditioned.

A recent analytic result was proposed by Ledoit and Wolf

(2003) to construct an improved covariance estimator that is not only suitable for
small sample size

n

and large numbers of variables

J

but meanwhile is also com-

pletely inexpensive to compute [74]. They suggested the linear shrinkage approach to
combine both single-index covariance matrix estimator and sample covariance matrix
estimator in a weighted average.

And they select the optimal shrinkage intensity

through explicitly minimizing a risk function for example the mean squared error
(MSE). It was based on the full sample covariance matrix. As illustrated earlier in
our cases, the sparse covariance matrix keeping the main high correlation part is reasonable and accurate to get close to the full sample covariance matrix. Working on
such sparse covariance matrix, the key problem is that if we can gure out some similar shrinkage procedure to get it positive denite and keep it sparse in the meanwhile.
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Shrinkage here is applied to the correlations rather than the covariances. This has
two distinct advantages. First, the o-diagonal elements determining the shrinkage
intensity are all on the same scale. Second, the correlations derived from the resulting covariance estimator are independent of scale and location transformations of the
underlying data matrix.

Working on the sparse matrix, we shrink the o-diagonal

entries of the sparse correlation matrix to zero gradually to reach the aim of positive denite matrix. We try the simple shrinkage on each entries of the sparse matrix.

In the following sections, I briey review the general principles behind shrinkage
estimation of the sparse and positive denite correlation matrix and discuss an analytic approach to determine the optimal shrinkage level and the number of sparse
diagonals.

4.4.2

Shrinkage estimation of sparse positive denite correlation matrix

As discussed above, we would get a symmetric sparse sample correlation matrix when
choosing an appropriate bandwidth. However, such sparse sample correlation matrix
could not be positive denite and thus it would have a lot of trouble when creating
the multivariate normal random vectors under the null. In this section I suggest using such sparse matrix obtained from the whole sample correlation matrix through a
transformation called shrinkage.

Dene

d to be the number of diagonals we calculate the pairwise correlation.

First

of all, it is noteworthy that here the

d has nothing to do with the bandwidth that we

need for kernel aggregation method.

d is used to obtain a sparse correlation matrix to

estimate the actual correlation while bandwidth is to calculate a nite set of aggrega-
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tions

{Tj }

T = maxj {Tj }.

leading to signicance testing based on the statistic

Figure 4.3, it is obvious that the choosing of
tion matrix. An appropriate

d

d

From

would eect the estimation of correla-

would have the sparse correlation matrix close to the

sample correlation and otherwise would get the estimation far away from the sample
correlation matrix.

Thus, the sparse matrix with dierent

d

will produce dierent

estimation through shrinkage. I will talk more about the eect of

d

on estimation of

correlation matrix.

In order to obtain positive denite correlation matrix and keep it sparse as well,
we have to shrink the elements on the sparse matrix. As we know, the correlation
between any two markers is a decreasing function of distance. Two nearby markers
would be highly correlated while two markers far apart are less correlated. Thus, it
is reasonable to consider shrinking the correlations by distance. We could shrinkage
the correlations a little bit for highly correlated marker and meanwhile shrink the
correlations more and more as the markers get farther and farther. In some sense,
the sparse matrix would be much closer to be positive denite when the correlations
are decreasing gradually by distance.

Thus, I consider the exponential decline by distance.
intensity and
with

j

Let

λ

be the shrinkage

j be the number of markers away between two markers.

markers away, I shrinkage the correlation by

element, the new correlation element

cor(i, i + j)0

(1 − λ)j .

For two markers

For any correlation

through shrinkage

cor(i, i + j)0 = cor(i, i + j) ∗ (1 − λ)j ,

(4.10)

In other word, working on the sparse matrix with calculated pairwise sample correlations for
marker

i

d

diagonals, every element with sample correlation

and marker

i+j

would transfer into
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cor(i, i + j)

cor(i, i + j) ∗ (1 − λ)j .

between

It makes some

sense because the correlations of markers far apart would shrinkage a lot more than
the nearby markers. After such shrinkage step, we generate a sparse matrix with the
gradually decreasing correlations by distance. It will become positive denite when
we choose an appropriate shrinkage intensity

4.4.3

λ.

Selection of the number of sparse diagonals and appropriate shrinkage intensity

By the shrinkage procedure, we are allowed to construct an improved correlation estimator in a sparse and positive denite matrix that is not only suitable for large
sample size

n

and large numbers of variables

pletely inexpensive to compute.

J

but at the same time is also com-

The larger the

λ,

the more shrinkage the sparse

correlation matrix gets. Thus, it will become positive denite more easily but meanwhile it changes the original correlations a lot and gets far away from the original
sparse sample correlation. A key question in this procedure is how to select an optimal
value for the shrinkage intensity. We wish to get a positive-denite correlation matrix
but shrinkage the correlations at minimum level. One common but computationally
intensive approach to estimate the minimizing
other widely applied route to inferring

λ

is by using cross-validation.

An-

λ views the shrinkage problem in an empirical

Bayes context. In our case here, the optimal shrinkage level could be determined analytically. We can simply choosing minimum

λ

that guarantees the positive-denite

structure of the sparse correlation matrix without the need of specifying any underlying distributions, and without requiring computationally expensive procedures such
as MCMC, the bootstrap, or cross-validation. In other word, the optimal shrinkage
level

λ

is determined by how sparse of the correlation matrix.
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Setting dierent number of sparse diagonals
by choosing minimum

λ

d,

shrinkage intensity is obtained

that guarantees the positive-denite structure of the sparse

correlation matrix. The relationship between
appears that shrinkage intensity

d

and

λ

is presented in Figure 4.4. It

λ becomes smaller as the number of sparse diagonals

increases. It makes sense in some sense because the sparse correlation matrix gathers
more information when

d is larger and then it is closer to the sample correlation which

0.15
0.10
0.05

Shrinkage intensity

is positive semi-denite and hence it does not require much shrinkage.

0

50

100

150

200

Number of sparse diagonals

Figure 4.4:

Eect of the number of sparse diagonals on optimal shrinkage intensity.

True CNV size is set be 50 and total number of markers is 500.

As shown above, the number of diagonals

d that we sparse the correlations also has

a lot of eects on the estimation of correlation matrix. Denote
used for kernel aggregation method while

d

bw

as the bandwidth

is the number of diagonals that create a

sparse correlation matrix. We always don't know either where the CNV is or the true
bandwidth of CNV. Basically we can choose any bandwidth for our kernel method.
It is shown that the larger bandwidth we choose for kernel aggregation method would
increase the power of detecting association between phenotype and intensities. After
choosing a bandwidth, the number of diagnose
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d

would include dierent correlation

information. Smaller

d

would get more sparse matrix while losing a lot more corre-

lation information. Furthermore,

d

choosing also eects type one error. The banded

sparse correlation matrix is more close to the whole sample correlation and includes
more information when

d

gets larger. By Theorem 2, when the estimated correlation

matrix gets much closer to the actual correlation matrix, the correlation approach
would preserve appropriate type one error. Therefore, we aim to select optimal

d

to

keep the correlation matrix sparse and also contain as much correlation information
and meanwhile preserve type one error as possible.

Figure 4.5 illustrates the relationship between

d

and type one error for dierent

bandwidth. For true CNV size of 50, we pick a set of bandwidths of 10,20,30,50,70,90
and 110, which include too small and too large bandwidth. Picking dierent number
of sparse diagonals for each bandwidth, the optimal shrinkage intensity

λs are chosen

to be minimum to guarantee the positive denite structure of sparse correlation matrix. From the plot, the eect of number of sparse diagonals on type one error are all
in the same trend for dierent bandwidths. Type one error goes down as increasing

d

until the type one error gets stable. Hence,

to preserve type one error.

d

needs to be larger than some choice

From simulation results, it seems to be safe to choose

d ≥ 3bw.

4.5

Simulation Results

I conducted simulation experiments in this section to evaluate the performance gain
that the correlation method provides and the cost in terms of its ability to detect
CNV-phenotype association.

I rst present the preservation of type one error of

correlation approach in dierent settings.
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Also, I compare the correlation method

Figure 4.5:

Eect of the number of sparse diagonals on preservation of type one error

when choosing dierent bandwidth for kernel aggregation method on normal signed
transformation. True CNV size is set be 50. The horizontal red line is for

α = 0.05

in dierent settings to permutation method in the distribution of the the estimated
null distribution of the supremum statistic

T = maxj {Tj }

under no CNV-phenotype

association. Then, comparison of the computing times applying dierent approach
to conduct the kernel-based aggregation of marker-level association test will give us a
measure of the performance gain. For all these simulations, I follow the spike-in data
design fully described in Section 3.4.

This procedure provides the simulation data

similar to the real data. For the simulations presented here, I use a sample size of

n = 1, 000
size of

and an total markers

n = 50

and

the case of large

4.5.1

J = 500

n,

large

J = 200

for large

assuming small

J .

n,

n,

large

small

J ;

and

J

setting; use a sample

n = 300

and

J = 500

in

Set signal-to-noise ratio of 2 for simulations.

Preservation of type one error

First of all, we are interested in the preservation of type one error of correlation
approach in each setting described above.
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Preservation of type one error is one

important aspect to determine the performance of the method. In dierent settings,
we all consider a genomic region in which individuals may have a CNV. The purpose of
the analysis is to detect and locate such CNVs associated with a particular phenotype.
The null hypothesis for our association test may hold in one of two ways: (1, No
CNV) no individuals with CNVs are present in the sample, or (2, No association)
individuals with CNVs are present in the sample, but the CNV does not aect the
disease and thus dose not change the probability of developing the phenotype. The
eect of transformations of

p-values

and association direction would be similar. In

this section, I focus on the analysis for dierent transformations of

p-values in signed

case. Simulation results are shown in tables and gures.

4.5.1.1

large

For large

n,

n,

small

small

J

J

setting

setting, I set

n = 1000

and

J = 200,

which is exactly the same

setting as permutation approach. The results for the FWER analysis are summarized
in Table 4.1 for dierent transformations of

p-values in signed direction of associations.

Table 4.1 perfectly demonstrates that correlation method under such setting is
guaranteed to preserves the correct type I error under both null hypothesis for dierent transformations in signed directions of association under linear model assumption
between phenotype and genotype. This phenomenon is also illustrated graphically in
Figure 4.6. Obviously, the correlation method to estimate the whole sample correlation is nice to apply since it preserves accurate type one error and

p-values under the

null appear to be uniformly distributed.

4.5.1.2

small

For small

n,

n,

large

large

J

J

setting

setting, I set

n = 50

and

J = 500

for simulation. As details

described before, the rank of the estimated sample correlation does not depend on the
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Table 4.1:

Preservation of Type I error for correlation method in large

n,

small

J

setting for dierent transformations in signed direction of association with nominal

α = .05

in two possible settings for which the null hypothesis holds. The simulated

genomic region contained 200 markers, 30 of which were spanned by a CNV with
signal-to-noise ratio of 2.

The CNV was present in either 0% or 50% of the 1000

samples, depending on the null hypothesis setting.

A detailed description of the

simulation data is given in Section 3.4.
Signed

Signed

Signed

None

Normal

Log

No CNV

0.041

0.042

0.046

No Association

0.043

0.046

0.046

No CNV
None−signed

0.0

0.0

0.0

0.2

0.2

0.2

0.4

0.6

No Association
None−signed

0.8

1.0

0.0

0.4

0.6
p

No CNV
Normal−signed

No Association
Normal−signed

0.4

0.6

0.8

1.0

0.0

0.2

0.4

0.6

p

p

No CNV
Log−signed

No Association
Log−signed

0.4

0.6

0.8

1.0

0.0

p

Figure 4.6:

0.2

p

0.2

0.4

0.6

0.8

1.0

0.8

1.0

0.8

1.0

p

Ability of correlation approach under dierent transformations in signed

directions of association for Large

n,

small

J

setting to maintain family-wise error

rate under the two null scenarios.

number of markers but on the sample size

n.

Applying singular value decomposition,

we simplify the correlation matrix and speed up the calculation. The results for the
FWER analysis are concluded in Table 4.2 for signed direction of associations with
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dierent transformations of
kinds of

H0

Table 4.2:

J  setting
α = .05 in

p-values.

And the distributions of

p-values

under two

are shown as well in Figure 4.7.

Preservation of Type I error for correlation method in small

n,

large

for dierent transformations and directions of association with nominal
two possible settings for which the null hypothesis holds. The simulated

genomic region contained 500 markers, 30 of which were spanned by a CNV with
signal-to-noise ratio of 2.

The CNV was present in either 0% or 50% of the 50

samples, depending on the null hypothesis setting.

A detailed description of the

simulation data is given in Section 3.4.
Signed

Signed

Signed

None

Normal

Log

No CNV

0.049

0.049

0.048

No Association

0.046

0.047

0.048

From the table and gure, it is pretty good results in terms of the preservation of
type I error and

p-values

under two null are close to uniform distribution. Therefore,

although it is quite diculty to estimate the whole sample correlation matrix using
tradition way under small

n,

large

J

setting, SVD approach provides a perfect al-

ternative to estimate the correlation matrix and conduct the kernel-base aggregation
of marker-level association test.

4.5.1.3

large

n,

large

Similarly, under large
markers

J = 500.

n,

J

setting

large

J

setting, I take

n = 300

and the total number of

Applying shrinkage approach, it is necessary to select an optimal

number of sparse diagonals and an appropriate shrinkage intensity.

As illustrated

in Section 4.4.3, the larger the number of sparse diagonal, the more information the
sparse correlation matrix includes and thus the more accurate estimate of correlation
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No CNV
None−signed

0.0

0.0

0.0

0.2

0.2

0.2

0.4

0.6

No Association
None−signed

0.8

1.0

0.0

0.2

0.4

p

p

No CNV
Normal−signed

No Association
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0.6

n,

large

J

setting for dierent

in signed association to maintain family-wise error rate

under the two null scenarios.

matrix, which requires less shrinkage. It is suggested to pick

d ≥ 3bw

from simula-

tions. Figure 4.5 shows that type one error tend to be stable when the number of
sparse diagonals is larger than one specic number. Therefore, as we do not know the
true CNV size, it will be better to pick a large

d

to preserve type I error and contain

the important correlation part while choosing a smaller

d

to keep it sparse. For the

simulation, I choose a bandwidth of 30 markers for kernel-based method and pick the
number of sparse diagonal

d = 150

and minimum shrinkage intensity

λ = 0.012

to

guarantee the sparse and positive-denite correlation matrix. The results of FWER
analysis are present in Table 4.3 and Figure 4.8.

Under large

n,

large

J ,

a lot of approaches can not be applied and thus corre-
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Table 4.3: Preservation of Type I error for applying shrinkage approach on correlation
method for dierent transformations in signed association with nominal
two possible settings for which the null hypothesis holds.

α = .05

in

The simulated genomic

region contained 500 markers, 30 of which were spanned by a CNV with signal-tonoise ratio of 2.

The CNV was present in either 0% or 50% of the 300 samples,

depending on the null hypothesis setting.
Signed

Signed

Signed

None

Normal

Log

No CNV
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0.047

0.038

No Association
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Ability of shrinkage approach under dierent transformations in signed

association to maintain family-wise error rate under the two null scenarios.

lation matrix is complicated to estimate. In terms of preservation of type one error,
the shrinkage method seems to be a nice choice to estimate the correlation matrix
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under this setting when picking a proper

4.5.2

d

and shrinkage intensity

λ.

Evaluating the estimated null distribution

It was clearly demonstrated that correlation approach in dierent settings successfully preserves type one error and thus they could be good to apply for estimation
of correlation matrix and conduct kernel-base aggregation of association tests. Then
we are interested in the estimation of the method under dierent settings.

To see

the estimate of the method, it would be appropriate to compare the estimated null
distributions. I use the same settings as picked in last section for simulation. For each
setting, I compare the null distributions for each setting when applying permutation
method, the whole sample correlation estimate, SVD and shrinkage approach to the
kernel-based aggregation of marker-level association test.

From Figure 4.9, Figure 4.10, Figure 4.11, the null distributions stay very close
under dierent settings. Thus, the estimate and analysis results of kernel-based association test would be similar for all those methods and we are capable to use those
approaches for each setting if not considering the performance. Besides, it is worth
to note that the shape of the null distributions are still similar to each other even if
we don't use the true CNV bandwidth.

4.5.3

Performance of correlation procedure

In the previous sections we showed that the estimated null distribution of correlation
method works well as the permutation method and they all successfully preserve type
one error. Thus, those correlation methods are good to use for any situation. Now, we
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Figure 4.9:

Comparison of null distribution through permutation and three cor-

relation methods under large

n,

small

J

setting.

The simulated genomic region

contained 200 markers, 30 of which were spanned by a CNV with signal-to-noise ratio of 2. Population CNV frequency was presented in 50% of 1000 samples. Signed,
normal transformation with bandwidth

bw = 20

was used for kernel-based method.

are more interested in evaluating the operating characteristics of correlation methods.
Unlike permutation method, the proposed correlation procedure involves the simulation of multivariate normal variables rather than the genotype or phenotype data
and does not require repeated analysis of simulated data sets. The estimate of correlation matrix involving the observed data is calculated only once, and the evaluation
of the null distribution given the estimated correlation matrix is trivial. Thus, the
proposed correlation approach provides a much more ecient procedure to generate
the null distribution than permutation approach. In this section we wish to assess
the reduction in computing time achieved by this procedure at no cost in terms of
false positive. We compare the performance of the correlation method to permutation
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Figure 4.10:

Comparison of null distribution through permutation and three cor-

relation methods under small

n,

large

J

setting.

The simulated genomic region

contained 500 markers, 30 of which were spanned by a CNV with signal-to-noise ratio of 2.

Population CNV frequency was presented in 50% of 50 samples.

normal transformation with bandwidth

bw = 20

Signed,

was used for kernel-based method.

approach in kernel-based aggregation of marker-level association test. We would like
to show the comparisons in terms of computation burdens and eciency in low and
high dimensions.

4.5.3.1

large

J

setting

As illustrated, correlation-based approach has extended to the high dimensions in
ecient way.

For large

J

setting, SVD approach is perfect for small sample size

and shrinkage is nice for large sample size. We set the total number of markers to
be 2000 for our simulation. When changing the sample size, the computation time
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Comparison of null distribution through permutation and three cor-

relation methods under large

n,

large

J

setting.

The simulated genomic region

contained 500 markers, 30 of which were spanned by a CNV with signal-to-noise ratio of 2. Population CNV frequency was presented in 50% of 300 samples. Signed,
normal transformation with bandwidth

bw = 20

was used for kernel-based method.

comparisons are presented in Figure 4.12. First of all, the black line stays a lot higher
than the other three lines. Obviously, correlation approach performs much better than
the permutation approach in terms of the computation burden. Furthermore, when
the sample size gets larger, the gap between the black line ant the other three lines
becomes wider. It makes sense since the sample size eects a lot on the computation
time of permutation approach. Permutation approach would consume a lot more time
as the sample size gets larger. More clear comparisons of three correlation methods
under the same setting are shown in Figure 4.13.

First, correlation method when

estimating the whole correlation matrix runs longer time than SVD and shrinkage
approach. It makes sense since the tradition correlation method estimates the whole
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correlation matrix while SVD and shrinkage just provide estimate of part of the
correlation matrix. In terms of the computation time, SVD approach is much better
than shrinkage approach when the simple size is much smaller and meanwhile the

300

500

Permutation
Correlation
SVD
Shrinkage

0

100

Consume time

700

shrinkage approach is getting better when the sample size gets larger.

0

500

1000

1500

sample size

Figure 4.12:

Comparison of computation time versus sample size between correlation

methods and permutation approach. We set total number of markers to be 2000 and
the total number of samples changes from 10 to 1910 by 100. CNV size are 30 markers.

4.5.3.2
In small

small

J

J

setting

setting, we set the total number of markers to be 200. While changing the

sample size from 10 to 1910 by 100, the consuming time versus sample size is present
in Figure 4.14. We see that the black line is always higher than the blue and the gap
becomes larger and larger as the sample size gets larger. Thus, correlation approach
is also much better than permutation approach even under low dimension. Besides,
the consuming time for correlation method is more stable by sample size because the
estimate of correlation matrix depends on the number of markers not the sample size.
It is remarkable that he correlation method runs no more than one second here for
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Figure 4.13:

Comparison of computation time versus sample size among three kinds

of correlation approaches. We set total number of markers to be 2000 and the total
number of samples changes from 10 to 1910 by 100. CNV size are 30 markers.

situation of 200 total number of markers. Note that here the correlation method is
giving the estimate of the whole correlation matrix.

This section demonstrates the performance of those methods and we would get
the conclusion that correlation approach is a better choice than the permutation approach in terms of the running time in both low and high dimensions.

Moreover,

the SVD and shrinkage method are well applied for high dimension and consume less
time than the tradition correlation method that gives the estimate of whole correlation matrix.
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Figure 4.14:

Comparison of computation time versus sample size between permu-

tation approach and correlation method for low dimension. We set total number of
markers to be 200 and the total number of samples changes from 10 to 1910 by 100.
CNV size are 30 markers.

4.6

Gemcitabine study

In this section we apply the correlation approach to the real data and then compare
it to permutation approach.

We begin by describing the design of a pharmacoge-

nomic study of gemcitabine, a commonly used treatment for pancreatic cancer. It is
the same data that is analyzed for application of permutation approach.

Then we

analyze data applying the proposed correlation method on kernel-based aggregation
association test.

The gemcitabine study was carried out on the Human Variation Panel, a model
system consisting of cell lines derived from Caucasian, African-American and Han
Chinese-American subjects (Coriell Institute, Camden, NJ). Gemcitabine cytotoxicity assays were performed at eight drug dosages (1000, 100, 10, 1, 0.1, 0.01, 0.001,
and 0.0001 uM) [60]. Estimation of the phenotype IC50 (the eective dose that kills
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50% of the cells) was then completed using a four parameter logistic model [61].
Marker intensity data for the cell lines was collected using the Illumina HumanHap
550K and HumanHap510S at the Genotyping Shared Resources at the Mayo Clinic in
Rochester, MN, which consists of a total of 1,055,048 markers [62, 63]. Raw data were
normalized according to the procedure outlined in [64]. 172 cell lines (60 Caucasian,
53 African-American, 59 Han Chinese-American) had both gemcitabine cytotoxicity
measurements and genome-wide marker intensity data. To illustrate the application
of the kernel-based aggregation approach, we selected one chromosome (chromosome
3) from the genome-wide data. To control for the possibility of population stratication, which can lead to spurious associations, we used the method developed by [65],
which uses a principal components analysis (PCA) to adjust for stratication.

At

each marker, a linear regression model was t with PCA-adjusted IC50 as the outcome and intensity at that marker as the explanatory variable; these models produce
the marker-level tests.

We analyzed these data using the kernel-based approach described in Section 2.2
with a bandwidth of 50 markers and the log transformation. Instead of permutation
method on kernel, we demonstrate the correlation approach. As known, correlation
method depends on the estimation of correlation matrix and there are a couple of
choice for the dierent settings. For the real data involving with 70,542 markers for
172 cell lines, it is denitely a huge correlation matrix. It would be out of memory
to calculate the complete sample correlation matrix. But the small sample size indicates that SVD will be a nice choice to estimate the correlation matrix. Also, we
could try the shrinkage method with appropriate shrinkage intensity and the number
of sparse diagonals.

We pick

d = 300

with minimum

λ = 0.03

here.

The results

are shown in Figure 4.15. Note the presence of a peak at 102.6 Mb. The horizontal
lines indicate the FWER-controlled, chromosome-wide signicance threshold at the
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α = 0.1

level. These two cutos are close. It makes sense since the null distributions

are close to each other shown in Section 4.5.2. As the gure indicates, there are both
insucient evidence in this study to establish a CNV association involving response
to gemcitabine (p

= 0.158

for SVD and

p = 0.204

for shrinkage) after controlling

the chromosome-wide FWER. Other choices of bandwidth and transformation would
produce qualitatively similar, although somewhat less signicant, results. Compared
to the result of permutation in Figure 3.2 on the same real data with the same setting, these cutos are close to the cuto of permutation approach, which is around
2.5. Note that the cuto of shrinkage method is a little bit higher than the SVD and
permutation approaches because shrinkage method losses correlation information to
some extent. Therefore, correlation method and permutation approach provide similar results in terms of the performance. In terms of consuming time, SVD approach
and shrinkage method run much faster than permutation, which requires resampling
and runs a few hours. For this study, SVD just needs a couple of minutes to run the
result and shrinkage require approximately 15 mins for kernel-based study plus extra
time to get sparse correlation matrix and nd out the optimal shrinkage intensity for
positive-denite correlation. Therefore, SVD approach would the best choice for such
data with much less sample size than the number of markers.
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Figure 4.15:

Analysis of the gemcitabine data (Chromosome 3) using the proposed

correlation method.

The kernel aggregations

Tj

are plotted against chromosomal

position. The red line indicates the cuto of SVD approach and the blue line shows
the cuto of shrinkage approach for chromosome-wide FWER signicance at the

α = .1

level.

86

Chapter 5 Summary and Discussion

This dissertation is devoted to the analysis of CNV-phenotype association testing.
Specially, we have reviewed the traditional and popular variant-level testing, which
do "CNV calling" rst for each individual and then carry out association test of
whether individual with a CNV dier from individual without a CNV with respect
to some phenotype.

We focus on the marker-level testing, where we do the asso-

ciation test for every single marker rst then determine CNV-phenotype associated
regions by pooling test results across neighboring markers. Here in the dissertation
we develop a kernel-based aggregation method for marker-level association test. Conducting such an association test, I propose a permutation approach and correlation
method to estimate the null distribution of the test statistic.

In summary, permutation tests provide a robust and powerful method of testing
statistical hypotheses that is intuitive and easy in practice.

More importantly, it

provides an accurate FWER control and does not rely on any model assumptions.
However, the permutation approach has its own limitations. First, this approach is
valid and widely used only under very mild conditions complete exchangeability
under null hypothesis as described above. Thus it may not be applicable when there
are covariates or nuisance parameters [57]. Especially, the permutation distribution
may not be appropriate when the analysis involves covariates that are correlated
with both genotype and phenotype. Moreover, it becomes computationally demanding since the analysis needs to be repeated for each permuted dataset while creating
the null distribution of test statistic. The kernel aggregation itself is very fast, but
the need to carry out

≈ 1, 000 permutation tests for each marker may be highly com-

putationally intensive, depending on the complexity of the marker-level test. Thus,
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the computing problem is critical for permutation approach.

The proposed correlation method is demonstrated to oer large improvements in
speed. First it does not involve repeated analyses of simulated datasets and is thus
provides a substantial gain in speed with only a negligible loss in accuracy. Second,
it does not require complete exchangeability and is thus widely applicable.

Thus,

correlation method appears to be a better choice than permutation in terms of the
computation time. Moreover, extending this method to high dimension, we develop
SVD and shrinkage method, which are presented to also preserve type one error and
require much less running time.

The simulation studies of Section 3.4 address a limited-scale version of a larger
question: how do marker-level test aggregation and variant-level testing compare for
chromosome-wide and genome-wide analysis? This is an important question and deserves further study. In general, multiplicity is a thorny issue for CNV analyses, as
the true location of CNVs are unknown and can overlap in a number of complicated
ways. The issue of how many tests to carry out and adjust for is a challenging question for variant-level testing and a considerable practical diculty in analysis.
contrast, aggregation of marker-level results avoids this issue altogether.

In

We have

shown that the proposed approach is both powerful at detecting CNV associations
and rigorously controls the FWER at a genome-wide level  two rather appealing
properties. However, future work applying the proposed method to larger, more complex settings is necessary.

In this dissertation, I have focused on continuous phenotype, with association testing performed using linear regression.

The kernel-based aggregation method itself,
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however, requires only

p-values

and can be extended to a more complicated marker-

level tests assuming nonlinear, mixed-eects, or mixture models between intensity
and phenotype. Furthermore, our simulations involve a very simple genetic scenario:
a small segment of DNA in which a single CNV is either present or absent. It is important and valuable to understand the properties of marker-level approach in these
simple cases. However, future research involving more complicated scenarios is also
needed.
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Appendices
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A.Proof of Theorem 1

Proof of Theorem 1.
the CDF of

Tmax

P

Let

over

P,

Tmax (X, y) > F0−1 (1 − α)

denote the set of all possible permutations of

and

F0−1

its generalized inverse. Also, let

{yi }, F0

φ(X, y) = 1

if

and 0 otherwise.

Now, note that under the null hypothesis that

P (X, y) =

Y

=

Y

xi

and

yi

are independent,

P (xi , yi )

i

P (xi )P (yi )

i

= P (X, y∗ )
for all

y∗ ∈ P .

Thus,

E0 φ(X, y∗ )

is a constant for all

y∗

and

1 X
E0 φ(X, y∗ )
n! y∗ ∈P
1 X
= E0
φ(X, y∗ )
n! y∗ ∈P

E0 {φ(X, y)} =

≤ α,
where the term inside the expectation in the second line is less than or equal to
all

X

and

y

by the construction of the test.
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α

for

B. Proof of Theorem 2

Proof of Theorem 2.
intensities

0

xj

and

y

Assume simple linear regression
for subjects

and standard deviation

yi − ȳ = yi0 sdyi ,

σ.

is,



where

By standardization, we dene

regression model, we have the

z -statistics

between

has a normal distribution with mean

where we denote standardized

Zj =

y = β0 + β1j xj + 

under

x0ij

and

yi0 .

xij − x¯j = x0ij sdxij

and

Under the simple linear

H0 :

βˆ1j − 0
s.e.
P

(xij −x¯j )(yi −ȳ)
P
(xij −x¯j )2

= p P
σ̂ 1/ (xij − x¯j )2
P
sdxij x0ij sdyi yi0 q
=
(n − 1)sd2xij
σ̂(n − 1)sd2xij
P 0 0
xij yi
=p
,
(n − 1)
where

P
(xij − x¯j )2 = (n − 1)sd2xij

Now, correlation between two
corresponding

z

σ̂ = sdyi .

and also

p-values is equivalent to the correlation between the two

statistics. Therefore, correlation between

z

statistics of two markers

is simplied by (4.2),

P 0 0
P 0 0
xij yi
x y
cor(zj , zk ) = cor( p
, p ik i )
(n − 1)
(n − 1)
X
X
= cor(
x0ij yi0 ,
x0ik yi0 )
X
X
= cor(
x0ij ,
x0ik ),
since under the null hypothesis that

xij

and

yi

are independent.

By (4.2) again,

X
X
cor(zj , zk ) = cor(
x0ij ,
x0ik )
= cor(xj , xk )
Thus,correlation structure among

p-values

matrix of the intensities among markers.
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under

H0

exactly equals the correlation

C. R code for Permutation Method

####kernel-based association test

## Input: X (matrix of intensity values)
##

y (vector of phenotypes)

##

FUN (If P and S are not supplied, must supply FUN

##

a function which carries out the marker-level testing;

##

must return vector of p-values or a list with components

##

'p' and 's' if signed aggregation is to be carried out)

##

bw (bandwidth)

##

pos (position of markers on chromosome)

##

trans (transformation)

##

test (if TRUE, calculates F0)

##

N (Number of permutations)

##

... (arguments passed to FUN)

## Output: T (test statistic)
##

p (p-value of t)

##

Tmax

kbag <- function(obj, ...) UseMethod("kbag")
kbag.permTest <- function(obj, ...)
{
if (attr(obj, "signed")) kbag.numeric(p=obj$p, s=obj$s, P=obj$P, S=obj$S, ...)
else kbag.numeric(p=obj$p, P=obj$P, ...)
}

kbag.function <- function(FUN, X, y, test=TRUE, N=1000, showProgressBar=TRUE, ...)
{
## Evaluate FUN
93

FUN.args <- as.list(formals(FUN))
dots <- list(...)
matched <- names(dots)[names(dots) %in% names(FUN.args)]
if (length(matched)) FUN.args[matched] <- dots[matched]
FUN.args[[1]] <- X
FUN.args[[2]] <- y
fun.val <- do.call(FUN, FUN.args)
signed <- FALSE
s <- S <- P <- NULL
if (is.numeric(fun.val)) {
p <- fun.val
} else if (is.list(fun.val)) {
p <- fun.val$p
if ("s" %in% names(fun.val)) {
s <- fun.val$s
signed <- TRUE
}
} else stop("FUN returns unrecognized format")

## Calculate P, S
if (test) {
P <- matrix(NA, nrow=N, ncol=ncol(X))
if (signed) S <- P
for (i in 1:N) {
FUN.args[[2]] <- sample(y)
res <- do.call(FUN, FUN.args)
if (!signed) P[i,] <- res else {
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P[i,] <- res$p
S[i,] <- res$s
}
if (showProgressBar) displayProgressBar(i,N)
}
}

if (signed) kbag.numeric(p, s, P=P, S=S, test=test, ...) else kbag.numeric(p, P=
}

kbag.numeric <- function(p, s, bw, X, N=1000, P, S, pos=1:length(p), trans=c("log"
{
## Aggregate
signed <- if (missing(s)) FALSE else TRUE
if (signed & missing(trans)) trans <- "normal"
trans <- match.arg(trans)
if (missing(bw)) stop("You must supply a bandwidth")

if (signed) {
if (trans=="none") x <- s*(1-p)
if (trans=="normal") x <- qnorm((1+s*(1-p))/2)
if (trans=="log") x <- -s*log(p)
} else {
if (trans=="none") x <- 1-p
if (trans=="normal") x <- qnorm(1-p)
if (trans=="log") x <- -log(p)
}
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out <- .C("KBAGN", double(length(p)-2*(bw-1)), integer(length(p)-2*(bw-1)), inte
T <- out[[1]]
names(T) <- pos[out[[2]]]
Tmax <- if (signed) max(abs(T)) else max(T)

## Calculate F0, test

#########This part will be different when applying different approaches to get F
if (test) {
if (missing(P)) {

if (missing(X)) stop("If test=TRUE, must supply either X (matrix of intensit
Sigma <- cor(X)
require(mvtnorm)
Z <- rmvnorm(N, sigma=Sigma, method="svd")
if (signed) {
P <- 2*pnorm(-abs(Z))
S <- sign(Z)
} else P <- 1-pchisq(Z^2,1)

}

F0 <- if (signed) getF0(P, S, bw=bw, pos=pos, trans=trans) else getF0(P, bw=bw
p.value <- 1-F0(Tmax)
} else {
p.value <- NULL
F0 <- NULL
}
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## Return

structure(list(Tmax=Tmax, p=p.value, F0=F0, T=T, signed=signed, bw=bw, trans=tra
}

## Obtains null distribution for Tmax using permutation testing
getF0 <- function(P, S, bw, pos, trans)
{
N <- nrow(P)
x <- numeric(N)
if (missing(S)) for (i in 1:N) x[i] <- kbag(P[i,], bw=bw, pos=pos, trans=trans,

else for (i in 1:N) x[i] <- kbag(P[i,], S[i,], bw=bw, pos=pos, trans=trans, test
ecdf(x)
}

###Simulation data
## n = number of subjects
## g = frequency of CNV
## m = number of SNPs / CNV
## snr = signal-to-noise ratio
## J = # of markers
## pen = penetrance
## standardized = standardize X and y?

genData <- function(n, g, m, snr=0.8, delta=1, J=200, pen, noise.type=c("spike","m
{
noise.type <- match.arg(noise.type)
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if (m%%2!=0) stop("m must be even")

## Generate y, z
if (missing(pen))
{
z <- rbinom(n,1,g)
y <- genY(n=n,delta=delta,z=z)
}
else
{
if (n%%2!=0) stop("n must be even in a case-control study")
y <- c(rep(0,n/2),rep(1,n/2))
p <- numeric(n)
p[y==1] <- g*pen[2]/(g*pen[2]+(1-g)*pen[1])
p[y==0] <- g*(1-pen[2])/(g*(1-pen[2])+(1-g)*(1-pen[1]))
z <- rbinom(n,1,p)
}

## Generate X
X <- Z <- matrix(0,nrow=n,ncol=J)
j <- c(-(J/2):-1,1:(J/2))
Z[z==1,abs(j) <= m/2] <- snr

if (noise.type=="spike") {
if (is.null(attr(R,"sd"))) {
sd.r <- sd(as.numeric(R))
} else sd.r <- attr(R,"sd")
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a <- sample(1:(ncol(R)-J),1)
markers <- sample(1:ncol(R),J)
noise <- as.numeric(R[sample(1:nrow(R),n,replace=TRUE),markers]/sd.r)
} else {
E <- matrix(rbinom(J*n,size=1,prob=.3),ncol=J)
R1 <- matrix(rdex(J*n,0,1),ncol=J)
R2 <- matrix(rnorm(J*n,0,1))
noise <- E*R1+(1-E)*R2
}
X <- Z + noise

val <- list(y=y,X=X,Z=Z,z=z)
if (noise.type=="spike") {
start <- sample(1:length(pos), 1)
val$pos <- pos[start:(start+J-1)]
}
if (standardized) {
val$X <- standardizeX(val$X)
val$y <- standardizeY(val$y)
}
val
}

genY <- function(n,delta,z,pen)
{
return(rnorm(n,mean=delta*z))
##yy <- rbinom(n,size=1,prob=pen[z+1])
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##return(list(y=y,yy=yy))
}

####standardize data
standardizeX <- function(X)
{
n <- nrow(X)
center <- colMeans(X)
X.c <- sweep(X,2,center)
scale <- sqrt(apply(X.c,2,crossprod)/(n-1))
sweep(X.c,2,scale,"/")
}
standardizeY <- function(y){(y-mean(y))/sd(y)}

#####linear regression between intensity and phenotype

mlt <- function(XX, yy, type=c("continuous", "discrete"), signed=TRUE, return.line
{
type <- match.arg(type)
if (type=="continuous") {
n <- length(yy)
if (standardized) {
b <- crossprod(XX,yy)/n
R <- yy - sweep(XX,2,b,"*")
t. <- b/(sqrt(apply(R,2,crossprod)/(n-2)/n))
} else {
meany <- mean(yy)
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y <- yy - meany
meanx <- apply(XX,2,mean)
X <- t(t(XX) - meanx)
Xy <- crossprod(X,y)
XX <- apply(X,2,crossprod)
b <- as.numeric(Xy/XX)
if (return.line) a <- meany-b*meanx
R <- y - t(t(X)*b)
t. <- b/(sqrt(apply(R,2,crossprod)/(n-2)/XX))
}
}
if (type=="discrete") {
n <- length(yy)
fit <- lm(XX~yy)
MSE <- apply(fit$residuals,2,crossprod)/(n-2)
SXX <- crossprod(yy-mean(yy))
SE <- sqrt(MSE/SXX)
b <- fit$coef[2,]
if (return.line) a <- fit$coef[1,]
t. <- b/SE
}
p <- 2*pt(-abs(t.),n-2)
if (!return.line & !signed) val <- p else val <- list(p=p)
if (return.line) val <- append(val,list(b=b, a=a))
if (signed) val <- append(val,list(s=sign(t.)))
val
}

101

####plot kbag result####
plot.kbag <- function(x,F0,alpha=.05,pch=19,cex=.1,ylim,...)
{
if (!missing(F0)) x$F0 <- F0
T <- x$T
Position <- as.numeric(names(x$T))
if (is.null(x$F0)) {
if (missing(ylim)) ylim <- range(T)
plot(Position,T,pch=pch,cex=cex,ylim=ylim,...)
} else {
cutoff <- quantile(x$F0,1-alpha)
if (x$signed) {
ylim <- range(c(T,-cutoff,cutoff))
plot(Position,T,pch=pch,cex=cex,ylim=ylim,...)
abline(h=cutoff,col="red",lwd=2)
abline(h=-cutoff,col="red",lwd=2)
} else {
ylim <- range(c(T,cutoff))
plot(Position,T,pch=pch,cex=cex,ylim=ylim,...)
abline(h=cutoff,col="red",lwd=2)
}
}
}

## Standardized
Data <- genData(n=300, g=0.5, m=50,delta=0, standardized=TRUE)
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mlt(Data$X, Data$y)$p[1:10] ## Same as below
mlt(Data$X, Data$y, standardized=TRUE)$p[1:10] ## Same as above
fit

<- kbag(mlt, Data$X, Data$y, bw=30, standardized=TRUE)

plot(fit)

###Demo
###permutation-based###
Data <- genData(n=300, g=0.5, m=50,delta=0)
fit

<- kbag(mlt, Data$X, Data$y, bw=30, test=FALSE)

fit

<- kbag(mlt, Data$X, Data$y, bw=30)

plot(fit)

## P
Data <- genData(n=300, g=0.5, m=50, delta=0, standardized=TRUE)
P <- S <- matrix(NA, nrow=1000, ncol=200)
for (i in 1:1000) {
res <- mlt(Data$X, sample(Data$y), standardized=TRUE)
P[i,] <- res$p
S[i,] <- res$s
displayProgressBar(i, 1000)
}
res <- mlt(Data$X, Data$y, standardized=TRUE)
fit <- kbag(res$p, res$s, P=P, S=S, bw=30)
plot(fit)
fit <- kbag(res$p, res$s, P=P, S=S, bw=50, trans="none")
plot(fit)
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D. R code for Correlation Method

#####Basic correlation method to get the whole sample correlation matrix#####

## Single example -- "manual"
Data <- genData(n=300, g=0.5, m=50, delta=0, snr=20)
res <- mlt(Data$X, Data$y)
Sigma <- cor(Data$X)
Z <- rmvnorm(1000, sigma=Sigma, method="svd")
P <- 2*pnorm(-abs(Z))
S <- sign(Z)
fit <- kbag(res$p, res$s, P=P, S=S, bw=30)
plot(fit)

## Single example -- "automatic"
Data <- genData(n=300, g=0.5, m=50, delta=0, snr=20)
res <- mlt(Data$X, Data$y)
fit <- kbag(res$p, res$s, bw=30, X=Data$X)
plot(fit)

## Simulation
N <- 500
p <- numeric(N)
for (i in 1:N) {
Data <- genData(n=300, g=0.5, m=50, delta=0, snr=20)
res <- mlt(Data$X, Data$y)
fit <- kbag(res$p, res$s, bw=30, X=Data$X)
p[i] <- fit$p
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displayProgressBar(i, N)
}
hist(p, col="gray", breaks=c(0,1,.01), border="white")

#####shrinkage approach
diags <- function(XX, d) {
X <- standardizeX(XX)
n <- nrow(X)
p <- ncol(X)
B <- matrix(0, p, d)
for (i in 1:p) {
for (j in 1:d) {
if (i+j > p) break
B[i,j] <- crossprod(X[,i], X[,(i+j)])/n
}
}
B
}

smoothB1 <- function(B,alpha) {
n <- nrow(B)
p <- ncol(B)
BB <- matrix(0, n, p)
for (i in 1:n) {
for (j in 1:p) {
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BB[i,j] <- B[i,j]*(1-alpha)^j
}
}
BB
}

multiz3h <- function(n=1000,XX, d,alpha) {
t<-ncol(XX)
require(Matrix)
require(psych)
B <- diags(XX, d)
BB<-smoothB1(B,alpha=alpha)

S <- bandSparse(nrow(BB), k=0:ncol(BB), diag=cbind(rep(1, nrow(BB)),BB), symmetr
cholS <- chol(S)
z<- array(rnorm(t*n),c(n,t)) %*% cholS

##see str(mvsamples)

z<-as.matrix(z)
return(z)

####give n*t matrix

}

###find the best shrinkage intensity
aa<-seq(0.1,0.15,0.01)
l<-length(aa)
N=500
s<-array(data<-0,dim=c(l,N),dimnames=list(aa,1:N))
for (i in 1: l)
{
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for (j in 1:N)
{
Data <- genData(n=50,g=0.5,m=100,delta=0,snr=2,J=500)
B <- diags(Data$X, 10)
BB<-smoothB1(B,alpha=aa[i])

###alpha=0.03 seems okay

S <- bandSparse(nrow(BB), k=0:ncol(BB), diag=cbind(rep(1, nrow(BB)),BB), symme
ss<-as.matrix(S)
s[i,j]<-sum(eigen(ss)$values < 0)

}
displayProgressBar(i, l)
}
S<-apply(s,1,sum)

#####Getting F0 and only change one part of kbag function

Z<-multiz3h(n=N,X,d,alpha)
###Or:
Data <- genData(n=300,g=0,m=30,delta=0,snr=2,J=500)
res <- mlt(Data$X, Data$y)
fit <- kbag2(res$p, bw=30,d=150,alpha=0.012, X=Data$X, trans="none")

#####Applying SVD on kbag function
## Single example -- "manual"
Data <- genData(n=50, g=0.5, m=30, delta=0, snr=2,standardized=TRUE, J=500)
nn <- N<-1000
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X<-Data$X
n=dim(X)[1]
X <- standardizeX(X)
ZZ <- matrix(rnorm((n-1)*nn), nn, n-1)
SVD <- svd(X, nu=0, nv=n-1)
A <- sweep(SVD$v, 2, SVD$d[1:(n-1)], "*")/sqrt(n)
Z <- tcrossprod(ZZ, A)
P <- 2*pnorm(-abs(Z))
S <- sign(Z)
fit <- kbag(res$p, res$s, P=P, S=S, bw=30)
##Or
fit <- kbag(res$p, res$s, bw=30, X=Data$X)
plot(fit)

© Yinglei Li, 2014.
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